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INTRODUCTION  This project investigated volumetric differences in certain subcortical structures 
as measured on high-resolution structural Magnetic Resonance Imaging (MRI) scans traced manually. 
The sample comprised 79 5-year old children, 52 with HIV and 27 uninfected controls. Infected 
children were all stable on antiretroviral therapy (ART) and were from the Children with HIV early 
antiretroviral (CHER) cohort who have been followed since birth. The study aimed to investigate the 
long-term effects of HIV and ART on the developing brain. While high-resolution structural data has 
been analysed using automated FreeSurfer to determine volume and cortical thickness, manual 
tracing remains the gold standard. Thus, manual tracing was used to validate automated measures 
and investigate subtle group differences in selected regions of interest.  
METHODS  Extensive clinical data were available for all participants in the study. MR images were 
AC-PC transformed and converted to analyse format. Structures were traced using MultiTracer 
software. Structures selected included the caudate, nucleus accumbens (NA), putamen (Pu), globus 
pallidus (GP) and corpus callosum (CC). Four of these structures occur bilaterally. Tracing was 
performed in 79 subjects. Three subjects were excluded due to poor quality images or pathology; 5 
HIV-1 infected children were excluded as they were not randomized between treatment groups. 
Certain subjects were retraced for inter and intrarater reliabilities. The effect and association of 
ethnicity, age, birthweight and sex as possible confounders were investigated. As the groups were not 
well matched for ethnicity, all Cape Coloured children were excluded from further analyses. Analysis 
of variance was used to test the effect on structure size between HIV-1 infected children and controls, 
as well as between 3 treatment arms (ART deferred until clinical criteria were met, early ART for 40 
weeks, early ART for 96 weeks) and uninfected controls. Analysis of covariance was used to control 
for the possible confounding effects of sex and age. Each structure was tested for possible association 
with clinical variables (CD4, CD8, CD4/CD8 ratio and CD4%) both at enrolment and time of scanning. 
Linear regressions were modelled using clinical variables that showed significant correlation with 
structure size whilst controlling for covariates. Congruence between automated FreeSurfer and 
manual segmentation were evaluated via Bland-Altman, Pearson r and Cronbach’s alpha.  
RESULTS   Uninfected controls were marginally older (5.6±0.5Yrs) than HIV-1 infected children 
(5.4±0.4Yrs) (F(1,61)=3.05,p=0.04). Bilateral NA and putamen were larger in HIV-1 infected children, 
whilst the CC was smaller. The largest differences were between children in the deferred treatment 
arm and uninfected controls. There were no differences between deferred and early treatment arms. 
Regression showed that age at scan was a greater predictor of size than other clinical measures, next 
to age at ART initiation and CD4/CD8 ratio at time of scan. While automated volumes correlated 
significantly with manual volumes in all grey matter regions, separate analyses within groups revealed 
significant differences between manual and automated segmentation in all structures except the left 
GP amongst infected children. 
DISCUSSION  Affected grey matter structures were larger in infected children, but decreased with 
age. This concurs with global atrophy observed in adults. This also suggests that damage occurs before 
5 years of age in HIV-1 infected children, causing the volume to initially be larger than in controls. The 
difference in effect size between early and deferred treatment arms suggests that early ART mitigates 
HIV-1’s effects on the affected structures. Since volumes in the left NA and bilateral putamen differed 
between the deferred treatment arm and controls, perturbations to motor learning, planning 
sequences and performance is expected in these children. This is substantiated by a previous study in 
the same cohort that reported lower general Griffiths and locomotor scores in the ART deferred group 
compared to children receiving early ART (Laughton et al. 2012). Although there were no differences 
between manual and automated volumes bilaterally in the caudate and GP, or CC, amongst uninfected 
children, automated and manual volumes differed in all regions except the left GP in infected children, 
indicating that subtle pathology may introduce bias between manual and automated measures in 
infected children. 
CONCLUSION Early ART mitigates the effect of HIV-1 infection in select structures, however atrophy 
still occurs with time. FreeSurfer may introduce bias into subcortical structure volumes in Xhosa 
children at, or around, 5 years of age. Caution should be employed when using automated 
segmentation to assess volume differences as a result of pathology in children. 
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CHAPTER 1 INTRODUCTION 
1.1 Research Rationale and Motivation 
Southern Africa is home to some of the most alarming statistics regarding HIV’s effect 
on humanity.  The UNAIDS census conducted in South Africa in 2011, indicated that 
approximately 5100 000 adults and 460 000 children are living with HIV/AIDS (WHO-UNAIDS 
2013).  The HIV/AIDS epidemic in 2003 accounted for around 5% of child mortalities within 
the Southern African region (Mahy 2003).  Since the advent of highly active antiretroviral 
treatment (HAART), HIV is no longer necessarily a fatal disease but more a chronic condition 
in which there may be ongoing damage to the body and central nervous system (CNS), 
especially in the developing brain of the fetus, infant and young child (van Rie et al. 2007; 
WHO-UNAIDS 2010).    
Tardieu and colleagues (2000) conducted a study on data collected in a French cohort of 
426 perinatally infected children and 1516 adults (Tardieu et al. 2000).  They found that the 
incidence of HIV associated encephalopathy was higher in children under the age of 5 years 
(9.9%) compared to adults (0.3%) in their first year post-infection (Tardieu et al. 2000).  In 
the second year, the incidence decreased to 4.2% in children while adults dropped to 0%, 
after which both groups showed incidences of encephalopathy of less than 1% per year 
(Mitchell, W 2001; Tardieu et al. 2000).   
Neurosis affects children differently and more dramatically than adults (Mitchell, W 
2001).  Neurological disease can occur before systemic immunodeficiency.  It has been 
shown that CNS maturation is impaired and language functions are affected more in infected 
children than in adults (van Rie et al. 2007).   Significant brain development in the first few 
years of life puts infected children at greater risk of neurological impairment as opposed to 
individuals infected later in life (Mitchell, W 2001; Tardieu et al. 2000).  Furthermore, HAART 
or other factors may cause neurodevelopmental impairment despite virological suppression 
in the CNS (van Rie et al. 2007; Tardieu et al. 2005).   
As CNS penetration by antiretroviral therapy (ART) is limited, the brain becomes a 
reservoir for the virus, and few drugs are available that impact these reservoirs (van Rie et 
al. 2007).  It is necessary to investigate the impact of HIV-1 infection on the developing brain 
and evaluate the extent to which damage to the CNS is mitigated by HAART.  Certain 
therapies have been flagged to have particular negative effects on brain development in 
children (Tardieu et al. 2005), it is thus also necessary to investigate whether the drugs used 
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in HAART may have any impact on brain development themselves in conjunction with HIV-1 
infection.   
Although automated image analysis tools such as FreeSurfer provide accurate cortical 
and subcortical segmentations, manual tracing still remains the gold standard and may have 
greater sensitivity to detect subtle morphometric differences.  Studies that have investigated 
similar research questions have made use of automated and semi-automated segmentation 
techniques to evaluate structural volume differences in the brains of HIV-1 infected 
individuals (Dewey et al. 2010; Heaps et al. 2012).  Automated measures are far less time 
consuming, less subjective, and more cost effective than manual tracing (Dewey et al. 2010).  
However, very little research has been done to investigate if the results from these 
automated techniques are reliable in measuring subcortical structural volumes in children, 
especially in children infected with HIV-1.   
Since neuroimaging studies of children with HIV are rare, even in developed countries, 
and often span a wide age range, very little is known about the effects of antiretrovirals (ARV) 
and HIV on the developing brain (Hoare et al. 2013; Laughton et al. 2012; van Rie et al. 2007; 
Tamula et al. 2003).  Hoare and colleagues (2013) compiled an extensive systematic review 
of relevant neuroimaging studies pertaining to the effects of vertically transmitted HIV on 
children and adolescents (Hoare et al. 2013).  The review took the form of a database search 
and a critical analysis of the search results (the review was submitted for publication on 3 
September 2013).  The databases searched were Pubmed, Medline, and Scopus.  The search 
criteria was a formation of keywords and included all possible combinations of words and 
phrases as both text and MeSH terms relating to HIV/AIDS, the brain and neuroimaging 
(Hoare et al. 2013).  The two investigators assigned to the task systematically evaluated the 
titles, abstracts, and keywords associated with each individual article and assessed their 
relevance.  Of 904 search results, 258 were found to be irrelevant to the scope of their 
review.  Of the remaining 646 journal article results, 427 included only HIV or neuroimaging 
separately, and 219 included both HIV and neuroimaging together (Hoare et al. 2013).  The 
inclusion criteria for further review and consideration were that the studies had to be original 
scientific outputs with a minimum of five subjects (0 to 18 years of age).  The subjects had to 
be diagnosed with HIV and either naïve to, or on ART or HAART.  They commented on the 
lack of literature pertaining to the subject, as well as the large assortment of imaging 
modalities employed to investigate the research topics, which made it impossible to compile 
a meta-analysis.  Few studies were found to be statistically relevant, if statistical methods 
were used at all.  There was a lack of descriptive variables and insufficient controls across 
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most studies.  The literature was too sparse to assess the changes the brain undergoes with 
increasing age in the presence of HIV infection (Hoare et al. 2013).   
At the time of writing, there have been no imaging studies that have comprehensively 
assessed using manual tracing structural brain changes in children vertically infected with 
HIV-1 and stable on ART (Hoare et al. 2013).   
Lindsey and colleagues (Lindsey et al. 2007 pp e681) have identified the need for this 
type of research on a large cohort followed from birth: “Additional longitudinal research is 
needed to better understand the role of antiretroviral therapy as well as the impact of 
genetic and environmental factors on neurodevelopmental functioning in children affected 
by HIV.” 
Similarly van Rie et al. (2007)highlighted the need for this type of research. As taken 
from Tamula et al. (2003): “It is therefore important to better understand the evolution of 
the child’s neurodevelopment following initiation of ART and to document the prevalence of 
and risk factors for discordance between control of HIV disease in the periphery versus the 
CNS.”  
Laughton et al. (2013) stated that little is known about the complex nature of brain 
recovery following ART initiation and reaffirmed that longitudinal research is needed to 
assess the long-term effects of ART and timing of ART initiation on neurodevelopmental 
outcomes in perinatally HIV-infected adolescents by gender, particularly in resource-
constrained settings.  
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1.2 Background 
The Children with HIV early antiretroviral therapy (CHER) trial investigated new 
approaches and strategies for treating HIV-infected children (Cotton et al. 2013; Laughton et 
al. 2009, 2012; Violari et al. 2008).  The CHER trial is supported under the umbrella of the 
Comprehensive International Program for Research on AIDS in South Africa (CIPRA-SA).  The 
CHER trial compared outcomes and prognosis in infants with perinatally acquired HIV-1 
infection, diagnosed between 6 and 12 weeks of age, who had been randomised into three 
treatment arms (Cotton et al. 2013; Violari et al. 2008).  The study postulated that starting 
ART earlier (before 12 weeks of age), followed by interruption of therapy, would show a long-
term benefit by preventing immunological and clinical progression of HIV-1 when compared 
with children in whom treatment was deferred until certain immunological criteria were met 
(Violari et al. 2008).   
The CHER study was an open-label randomised controlled trial comprising 377 HIV-1 
infected asymptomatic infants born to seropositive mothers (Cotton et al. 2013).  Pregnant 
women were recruited from the public prevention of mother-to-child transmission (PMTCT) 
programmes in the Western Cape and Gauteng provinces.  In the Western Cape province, 
Zidovudine (ZDV, AZT, Retrovir®) was administered to mothers from 34 weeks gestation and 
to neonates for 7 days. Additionally, a single dose Nevirapine (NVP, Viramune®) was given to 
mothers in labour and to infants shortly after birth. HIV infection was confirmed by a positive 
polymerase chain reaction (PCR) test for HIV-1 DNA and plasma viral load (PVL) > 1000 HIV-
1 RNA copies/ml.  The timing of administration of PMTCT treatment is vital as it reduces the 
risk of mother-to-child transmission and takes into consideration the known complications 
of zidovudine treatment at an early gestational age.  Treatment of zidovudine at an early 
gestational age has been linked to increased risk of mitochondrial dysfunction and 
neurological disorders in neonates (Tardieu et al. 2005).   
Infants between 6-12 weeks of age testing positive for HIV-1 infection with a percentage 
of CD4+ T-lymphocytes (CD4%) higher than 25%, were randomly allocated to one of three 
treatment arms (Cotton et al. 2013): 
 ART-Def (ART deferred until CD4% < 25% in first year or CD4% < 20% thereafter,
or if clinical disease progression criteria presented)
 ART-40W (ART initiated early – i.e., as close as possible to age 6 weeks – and
interrupted after 40 weeks), and
 ART-96W (ART initiated early and interrupted after 96 weeks).
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Re-initiation of treatment occurred if CD4% dropped below 25% or CD4+ T-lymphocyte 
count fell below 1000cells/mm3.  Secondary criteria for re-initiation of treatment were 
certain severe clinical events (refer to Cotton et al. 2013-appendix pp 131-133).  The CHER 
study showed that early HIV diagnosis and early ART reduce early infant mortality by 76% 
and HIV progression by 75% (Violari et al. 2008).  Early time-limited ART resulted in better 
clinical and immunological outcomes than deferred ART (Cotton et al. 2013).   
A neurodevelopmental sub study of the CHER trial evaluated the effect of early versus 
deferred ART on the neurodevelopmental outcomes in children from the CHER trial residing 
in Cape Town (Laughton et al. 2009). These children have undergone regular clinical and 
immunological follow-up, including comprehensive neurodevelopmental testing at the 
Children’s Infectious Diseases Clinical Research Unit (KID-CRU) at Tygerberg Hospital. The 
children all returned to KID-CRU at age 5 for their final neurodevelopmental assessment. At 
this time, a subset of the participants received high-resolution neuroimaging using custom 
developed sequences that have been optimized for paediatric imaging and that include real-
time motion correction in order to investigate the effects of HAART and HIV on the 
developing brain.   
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1.3 Overview of HIV-1 Infection 
1.3.1 Human Immunodeficiency Virus – 1 
Human immunodeficiency virus-1 (HIV-1) is a complex retrovirus within the Lentivirus 
genus (Cullen 1992).  The genomic organization and viral gene expression, which is controlled 
by interactions between cis-acting viral RNA (vRNA) sequences and host cell trans-acting 
factors, gives HIV-1 its complexity, while its ability to reverse the process of transcription 
(RNA to DNA) makes it a retrovirus (Cullen 1992). HIV-1 is a linear single stranded RNA 
(ssRNA) virus that is composed of nine genes that encode for viral gene products that are 
involved in structural or enzymatic functions.  These genes are divided into three standard 
genes in the retrovirus family, namely gag, pol, and env, which is flanked by long terminal 
repeats (LTRs) and six accessory genes, vif, vpr, tat, rev, vpu, and nef (in the form: 5’ LTR-gag-
pol-vif-vpr-tat-rev-vpu-env-nef-LTR 3’) (Cullen 1992; Ochsenbauer et al. 2012).  The 5’ LTR 
region promotes viral transcription by coding for enhancer and promoter elements that are 
necessary for transcription to occur (Cullen 1991, 1992).   The 3’ LTR region contains 
sequences that allow for polyadenylation of the messenger RNA (mRNA) (Cullen 1991, 1992).  
The gag gene encodes for virion structural proteins, the pol gene encodes for various 
enzymes, the env gene encodes for the precursor envelope glycoprotein (gp) 160, which is 
later cleaved into gp120 and gp41 that function in host tropism and membrane merging, 
respectively (Ashkenazi & Shai 2011; Cullen 1992).  Both tat and rev genes regulate gene 
expression and replication by acting in trans against the normally cis isoform of genes.  The 
tat gene is associated with increased viral gene expression and is regulated by its gene 
products, while the rev gene is necessary for the generation of structural proteins by inducing 
splice mechanisms of vRNA and has been linked as a transport molecule for pre-mRNA from 
the nucleus to the cytoplasm (Fischer et al. 1995).  The Nef and Vpu proteins downregulate 
the surface expression of the CD4 receptor and major histocompatibility complex (MHC) 
class I, while Nef further causes T-cell activation (Kirchhoff 2010; Malim & Bieniasz 2012). 
The vif and vpu genes are essential for viral maturation and release of virion particles.  The 
final gene product, Vpr, is a structural protein found in the virion and its gene vpr has been 
found to enhance replication rates of HIV-1 in culture (Cullen 1992). 
7 
1.3.2 HIV-1 Life Cycle 
The genes and their products play an important role in the life cycle and even the 
evolution of the virus (Cullen 1991).  Infection of the host cell occurs when the viral surface 
glycoprotein, gp120, directly binds to a CD4 receptor on the surface of mammalian target 
cell types (T-cells, macrophages/monocytes, and microglia) as well as a coreceptor, either 
CCR5 or CXCR4 (Musich et al. 2011).  This binding leads to conformational changes and 
exposure of the gp120-associated fusion protein, gp41, to the external environment.  The N-
terminus of the gp41 fusion protein then undergoes structural changes, which facilitates the 
insertion of the protein into the cell membrane of the host cell (Berger, Murphy & Farber 
1999; Lawless et al. 1996).  Fusion of viral and host cell membranes allows for the viral 
nucleocapsid (the viral genome inclusive of the protein coat) to enter the host cell cytoplasm 
(Pollard & Malim 1998).  Viral linear ssRNA is reverse-transcribed into linear double-stranded 
(ds) DNA by the viral enzyme reverse transcriptase (RT) and enters the host nucleus as the 
preintegration complex (nucleic acid-protein complex) (Pollard & Malim 1998).  The complex 
is then incorporated into the host cell’s genome by another virally encoded enzyme, 
intergrase, thereby forming the provirus, the viral transcriptional template (Brik & Wong 
2003; Pollard & Malim 1998).  
Viral transcription and translation (viral replication) occurs when the host cell is 
activated (Brik & Wong 2003).  The 5’ LTR region contains two binding sites for the inducible 
host transcription factor, NF-κB that is involved in cellular response to infection by activating 
cytokines and cytokine receptors, and acute phase protein genes.  HIV-1 activates host T-
cells via nef proteins and utilizes the activated NF-κB to enhance viral gene expression; 
therefore viral replication occurs at sites of inflammation (Cullen 1991).  Viral replication is 
divided into two phases based on the mRNA produced: the early regulatory phase, consisting 
of multiple splice (~2kb) regulatory mRNA for proteins nef, rev, and tat; and the late 
structural phase, consisting of unspliced (~9kb) and singly spliced (~4kb) mRNA for structural 
proteins.  The tat gene product regulates the increase in viral gene expression, which in turn 
causes the increased expression of the rev protein that is required for the switch between 
these two phases (Cullen 1991).  The final virally encoded enzyme, HIV protease, cleaves the 
polyprotein precursors into mature proteins, which are assembled at the cell surface forming 
new virions (Brik & Wong 2003). The gag and pol proteins assemble around two copies of 
the full length vRNA to form the immature nucleocapsid.  The outer capsular layer is formed 
during budding where the host cell membrane containing Env proteins surrounds the 
nucleocapsid (Pollard & Malim 1998). 
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1.3.3 HIV-1 Tropism 
HIV-1 tropism has been linked to the gp120 subunit of the env protein (Feng et al. 2011). 
The concept of tropism is used to reflect the preference of env’s activity to specific 
coreceptors that are expressed on specific target cell types (Berger, Murphy & Farber 1999). 
These coreceptors are (C-X-C chemokine receptor type 4) and CCR5 (C-C chemokine receptor 
type 5), where T-cell lines [(TCL)-tropic] have a preference for CXCR4, macrophage (M)-tropic 
have a preference for CCL5, and dual-tropic have a preference for both coreceptors.  
However, it is important to note that this preference is not the rule, i.e. there are cells, other 
than macrophages, that have a preference for CCR5 (Berger, Murphy & Farber 1999).  CCR5 
has been associated with early disease progression, HIV-1 transmission, and spreading 
capacity, while CXCR4 has been associated with late disease progression, especially in adults, 
and a rapid decline in CD4 T-cells leading to death (Mariani et al. 2012; Musich et al. 2011). 
Macrophages express low levels of CD4, which is required for HIV-1 infection of these 
cell lines.  M-tropism has been linked to protein changes in the CD4 binding site, which can 
directly impact CD4 affinity or affect exposure residues to CD4 (Musich et al. 2011).  The 
study of macrophages are becoming increasingly important, especially when they become 
infected, because they have a long-lifespan and have access to immunoprivileged sites such 
as the brain; therefore, they are important cellular reservoirs (Mlcochova et al. 2014).   
1.3.4 Host Defence Mechanisms and Susceptibility 
The response and susceptibility of the host cell to infection is largely based on the host 
genetic and immunological factors (Mackelprang et al. 2008), and the mutational adaptation 
of the virus to evade host responses (Kirchhoff 2010; Malim & Bieniasz 2012).  
Mammalian cells have developed innate defence mechanisms in response to viral 
infection, by utilizing proteins, termed restriction factors, to suppress viral replication (Malim 
& Bieniasz 2012). These intrinsic factors include the apolipoprotein B mRNA-eliciting enzyme 
catalytic polypeptide-like 3 (APOBEC3) family (especially APOBEC3G), tetherin, and tripartite-
motif-containing 5α (TRIM5α) (Kirchhoff 2010; Malim & Bieniasz 2012).  APOBEC3G protein 
is widely expressed in human cell types, and becomes incorporated into the gag region of 
the nucleocapsid of the assembling virion.  During viral replication, it causes positive strand 
guanine to adenine hypermutations, leading to a decrease in genetic integrity, which may 
also lead to viral diversity and evolution, especially if it results in immune escape or drug 
resistance (Malim & Bieniasz 2012).  The cytoplasmic protein, TRIM5α, is associated with 
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failure in viral dsDNA synthesis via premature viral uncoating and cross-species transition of 
HIV-1 (Kirchhoff 2010; Malim & Bieniasz 2012).  Another restriction factor, tetherin, allows 
for the maturation of virions but does not allow the matured virions to be released from the 
cell surface of infected cells (Kirchhoff 2010).  However, HIV-1 has developed mechanisms to 
evade these host intrinsic factors with the protein associated as the accessory genes, namely 
vif (inhibits APOBEC3G) and vpu (inhibits tetherin) (Malim & Bieniasz 2012). 
Host acquired immunity, especially CD8 T-cells, play an important role in controlling viral 
replication and in viral suppression (Zhang et al. 2002).  CD8 T-cells have the ability to directly 
kill infected cells (Kirchhoff 2010) and secrete soluble factors, CD8 antiviral factors (CAF), 
which have been shown to inhibit non-specific tropic viral replication (Zhang et al. 2002).  
CD8 T-cells further secrete β-chemokines (CCL5/RANTES and the macrophage inflammatory 
proteins MIP-1α and MIP-1β), which block M-tropic HIV-1 infection (Zhang et al. 2002). 
The final component conferring protection from disease progression to a susceptible 
host cell is the genetic make-up of the individual, since human variation is an important 
indicator of disease progression (Fellay et al. 2007).  Fellay and colleagues (2007) identified 
polymorphisms in the MHC or human leukocyte antigens (HLA) class I genes that explain 
variation in viral load and HIV disease progression amongst HIV-1 infected individuals (Fellay 
et al. 2007).  These polymorphisms result in variation in antigen presentation or increase the 
likelihood of viral escape, and, therefore, can be used as determinants of disease progression 
and susceptibility (Farquhar et al. 2004). This is due to the fact that different HLAs lead to 
the activation of cellular immune responses towards a specific HIV-1 epitope.  This immune 
response exerts immune pressure on HIV-1, leading to viral mutations that increase the 
chance of immune escape (Mackelprang et al. 2008).  Genetic polymorphism in the CCR5 
promoter region and increased chemokine SDF-1 levels have been linked to delayed disease 
progression but not transmissibility.  CCR5 polymorphisms may lead to varying regulation in 
the CCR5 gene transcript, while increased SDF-1 levels are thought to block its ligand, CXCR4, 
thereby preventing the attachment of HIV-1 to the coreceptor (McDermott et al. 1998).   
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1.3.5 Viral Load, CD4 and CD8 T-cell Count Monitoring 
Upon initial diagnosis of a positive HIV infection in adults, the relative stage of disease 
progression is determined by CD4 T-cell count and viral load (VL).  However, further 
monitoring of these biomarkers in the presence of ART initiation is controversial.    
Monitoring of VL has been indicated as a biomarker for treatment efficacy (Reynolds et 
al. 2014).  This in turn also aids in reducing the risk of genotypic resistance and of morbidity 
associated with advanced immune suppression (Reynolds et al. 2014).  VL is also a tool to 
improve adherence to ART, indicating patients with the need for enhanced adherence 
support, thereby providing an additional benefit to treatment programs/trials (Bonner et al. 
2013; Reynolds et al. 2014).  Immune activation and expansion of CD8 T-cell populations are 
also caused by HIV infection (Shearer et al. 2007).   
The necessity of sustained CD4 T-cell count monitoring has been questioned in the era 
of viral load suppression resulting from ART (Gale et al. 2013; Girard et al. 2013; Reynolds et 
al. 2014).  It has been reported that individuals with virologic suppression (VL ≤ 400 RNA/mL) 
and an immunological response to ART, have a very low risk of CD4 T-cell count below 200 
cells/µL (Reynolds et al. 2014).  This finding by Reynolds and colleagues (2014) on 1553 adult 
Ugandan patients is in accordance with that described in North America (Gale et al. 2013; 
Girard et al. 2013). CD4 T-cell count also tends to fluctuate throughout the day.  Children 
have a naturally high CD4 T-cell count, which decreases with age, and thus differs greatly 
from that of adults (Shearer et al. 2007).  As MTCT occurs around the time of birth, or during 
breastfeeding, the initial CD4 T-cell count in HIV positive infants is often equivalent to that 
of HIV negative infants(Shearer et al. 2003, 2007).  Studies on untreated adults show that 
CD8 T-cell activation occurs early after primary infection, whereas CD4 T-cell count decreases 
over time (Deeks et al. 2004). It should be noted that a subpopulation of CD8 T-lymphocytes, 
CD38+, linked to immaturity and recent thymic emigrants is also high in infancy and 
decreases with time (Paul et al. 2005).  High CD8 T-cell count has been associated with more 
advanced disease progression in HIV-infected children (Paul et al. 2005).  Either CD4 
percentage (CD4%) or CD4/CD8 ratio are suggested as more reliable predictive biomarkers 
of HIV-1 infection and disease progression in children than CD4 T-cell count.  CD4% is the 
relative percentage of lymphocytes that are CD4 cells within a given blood sample.  CD4/CD8 
ratio is the amount of CD4 T-cells relative to a single CD8 T-cell.  In infants, CD4/CD8 ratio 
has been described as a more reliable diagnostic marker than CD4 T-cell count alone (Shearer 
et al. 2007).      
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1.3.6 Mother to Child Transmission 
Mother to child transmission (MTCT) has been linked to HIV-1 tropism and genetic 
variation (Cavarelli & Scarlatti 2011; Mariani et al. 2012).  Mother to child transmission 
occurs during gestation, intrapartum, through the placenta or breast milk by ingesting 
infected fluids (Cavarelli & Scarlatti 2011; Mackelprang et al. 2008). 
The tropism of the HIV-1 strain of the mother plays an important role in the transmission 
from mother to child.  Mothers having CXCR4-tropic or dual-tropic HIV-1 strains have been 
found to have an increased likelihood of MTCT than those with CCR5-tropic strains, and if 
MTCT does occur, the CCR5-tropic strain is most likely the cause of infection in the fetus 
(Mariani et al. 2012).  In children, infection with the CXCR4-tropic HIV-1 strain usually result 
from the evolution of the initial infected CCR5-tropic strain to the CXCR4-tropic strain, as 
seen in adults during disease progression (Cavarelli & Scarlatti 2011; Mariani et al. 2012). 
HLA variation between mother and child further influence the susceptibility of the fetus 
to MTCT (MacDonald et al. 1998; Mackelprang et al. 2008).   The more genetically identical 
(concordant) the HLA alleles are between mother and child, the higher the risk of perinatal 
infection in the absence of prophylaxis (Mackelprang et al. 2008).  In HLA concordance, 
viruses that have evaded maternal responses will also evade fetal responses because they 
are genetically similar in immunity (MacDonald et al. 1998; Mackelprang et al. 2008).  The 
more alleles the mother shares with the fetus the more rapid HIV-1 disease progression in 
the fetus.  Genetic differences in the HLA alleles (discordant) between the mother and child 
are thought to play a protective role against perinatal transmission because the immune 
response of the fetus can act against infected maternal cells or free virions (Mackelprang et 
al. 2008).  It would thus follow that the more genetically different and discordant the HLA 
alleles between any two individuals the more protected the recipient is against transmission, 
and if infected it leads to slow disease progression.  That is if the dissimilar HLA alleles in the 
recipient provide enough immune pressure on the incoming HIV-1 variant.  Whether the 
principle stated above can be extrapolated upon to that of different genetic population 
groups (such as transmission between Xhosa and Cape Coloured populations) is still a matter 
of further research and debate (Abubakar et al. 2008; Gray et al. 2013; Hoare et al. 2012; 
Violari et al. 2008).   
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1.3.7 HIV-1 Outcomes in Children versus Adults 
HIV-1 infection outcomes in perinatally infected children is highly variable and is largely 
based on the gestational period of fetal HIV-1 infection, immunocompetent status of the 
child or mother (HLA concordance), viral load, and biological phenotype (Cavarelli & Scarlatti 
2011).  Large differences in HIV-1 infection rate and progression have been identified 
between children and adults (Mariani et al. 2012; Tardieu et al. 2000). Firstly, approximately 
50-70% of HIV-infected adults present with mononucleosis-like symptoms, compared to 
approximately 75% of infants (Cavarelli & Scarlatti 2011; Mariani et al. 2012).  These 
mononucleosis-like symptoms extend to that of fever, acute pharyngitis, swollen glands, 
fatigue, malaise, and body pains.  Secondly, infants have a higher plasma viral load in their 
first month of life than adults, and the decrease in viral load takes years (in the absence of 
combination antiretroviral therapy) rather than months leading to a longer viral exposure 
time in infants (Cavarelli & Scarlatti 2011; Mariani et al. 2012). Thirdly, adults remain clinically 
asymptomatic after primary exposure compared to approximately 25% of infants that 
become symptomatic and progress to acquired immunodeficiency syndrome (AIDS) within 
the first year of life (Cavarelli & Scarlatti 2011; Mariani et al. 2012).   
1.3.8 Summary of the Mechanism of HIV-1 Infection 
Upon initial entry of HIV into the human body it infects immune cells carrying CD4 
receptors, thereby evading the immune response designed to eliminate it.  The virus enters 
the immune cell and utilises the immune cell’s infrastructure to replicate.  This results in the 
release of toxins and cytokines, by both the virus and immune cell respectively, causing 
inflammation.  This activates more immune cells carrying CD4 receptors that are recruited in 
response to the infection.  These recruited immune cells in turn become infected allowing 
the cycle to continue.  Additional immune pressures exerted upon HIV by the immune cells 
allow it to mutate which increase the chance of viral immune escape.   
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1.4 ARV Drugs and Their Action: CHER Trial (Cotton et al. 
2013) 
First Line ART 
First line ART includes the following drugs: 
 Zidovudine (Esposito, Corona & Tramontano 2012; Ghodke et al. 2012)
Zidovudine is a member of the nucleoside analogue reverse transcriptase inhibitor
(NRTI) family.  It competes with thymidine triphosphate, a nucleotide that is utilised by 
reverse transcriptase during conversion from ssRNA to dsDNA. Incorporation of zidovudine 
(which lacks the 3’ hydroxyl group) instead of thymidine triphosphate causes chain 
termination and thus inhibits HIV-1 replication.   
 Lamivudine (Esposito, Corona & Tramontano 2012)
Lamivudine is similar to zidovudine, but it competes with cytosine triphosphate instead
of thymidine triphosphate.  It also inhibits the replication of HIV-1 by causing chain 
termination.   
 Lopinavir-ritonavir (Bazzoli et al. 2010)
Lopinavir-ritonavir are protease inhibitors, which prevent the cleavage of the precursor
proteins by HIV proteases to form activated proteins required in the construction of new 
virions. 
Second Line ART 
Second line ART includes: 
 Didanosine (Esposito, Corona & Tramontano 2012)
Didanosine is also an NRTI, but is an adenine analogue instead of thymidine
triphosphate.  It inhibits the replication of HIV-1 by causing chain termination. 
 Abacavir (Esposito, Corona & Tramontano 2012)
Same as Zidovudine but is a guanosine analogue instead of thymidine triphosphate.  It
inhibits the replication of HIV-1 by causing chain termination.  
 Nevirapine and Efavirenz (Esposito, Corona & Tramontano 2012)
Both nevirapine and efavirenz are part of the non-nucleoside reverse transcriptase
inhibitor (NNRTI) family.  This group noncompetitively binds to a hydrophobic pocket in the 
reverse transcriptase structure.  The pocket is located near the polymerase active site and 
binding leads to conformational (structural) changes in reverse transcriptase, which in turn 
inhibits the elongation of DNA during DNA synthesis.   
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1.4.1  Adverse Effects of HAART 
The possibility of curing the HIV epidemic via current therapy regimens seems unlikely 
(Carr & Cooper 2000).  Indefinite use of antiretroviral therapy is needed to preserve clinical 
benefits.  Due to the rapid spread of the HIV epidemic there was an increased need for 
initiation of treatment, so that licencing of antiretroviral agents were accelerated (Carr & 
Cooper 2000).  The increased rate of pharmaceutical licencing meant the possible negation 
of studying long-term effects to such treatments.  When HIV-1 infected individuals initiate 
HAART, they often take at least three drugs to manage their condition (Carr & Cooper 2000).  
With the number of drugs on the market the possible number of HAART combinations is 
large.  As HIV has progressed from a terminal disease to a chronic illness, drug-related toxicity 
is becoming increasingly common.   
Common acute side effects to ARVs, which could occur in both adults and children, 
include hypersensitivity reactions, impaired concentration/CNS function, fatigue, myaligia, 
distal pain, anaemia, nausea, abdominal pain, vomiting, and diarrhoea (Ammassari et al. 
2001; Carr & Cooper 2000).  Hypersensitivity reactions usually manifests after 1-3 weeks of 
therapy, as an erythematous, maculopapular, pruritic and confluent rash (Carr & Cooper 
2000).  Adverse effects linked to efavirenz, nevirapine, and sometimes delavirdine, manifest 
mostly within the CNS (Carr & Cooper 2000).  The side effects often present clinically as 
dizziness, insomnia, somnolence, impaired concentration, vivid dreams, nightmares, and 
mania in about 40% of patients in the first few days to weeks of treatment (Ammassari et al. 
2001; Carr & Cooper 2000).  Women receiving nelfinavir or nevirapine are at increased risk 
of hyperglycaemia, hepatoxicity and gastrointestinal symptoms during pregnancy 
(Timmermans et al. 2005).   
Mitochondrial toxicity, a major adverse effect resultant from NRTIs (and NNRTIs), is not 
necessarily reversed over time (Mitchell, Wendy 2001; Tardieu et al. 2005; Venerosi, 
Calamandrei & Alleva 2002).  This involves inhibition of DNA polymerase γ.  The result is 
impaired synthesis of mitochondrial enzymes which generate adenosine triphosphate (ATP) 
by oxidative phosphorylation (Carr & Cooper 2000).  Mid to long-term adverse effects from 
such mitochondrial toxicities may include myopathy, neuropathy, hepatic steatosis, lactic 
acidaemia, pancreatitis, and possibly peripheral lipoatrophy (Carr & Cooper 2000).  A group 
of French scientists conducted a study to assess the effects of prenatal exposure to 
Zidovudine in uninfected children born to seropositive mothers (Tardieu et al. 2005).  Of the 
49 children in the cohort, 22 had mitochondrial dysfunction.  Fourteen without 
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mitochondrial dysfunction had unexplained neurological symptoms, and only 6 children 
were completely asymptomatic (Tardieu et al. 2005).  The images showed global 
antiretroviral-induced mitochondrial dysfunction in many of the brains within the cohort, 
mimicking that of congenital mitochondrial disease; the exception being that the 
mitochondrial dysfunction was confined to the CNS of the children, with none of the children 
showing signs of systemic mitochondrial dysfunction (Tardieu et al. 2005).   
Ramos-Sanchez and colleagues (2014) examined the side effects of Indinavir (a potent 
protease inhibitor often used in conjunction with NRTIs) in vivo in a hamster model receiving 
both normal or high-fat diets (Ramos-Sanchez et al. 2014).  They observed that with 
increasing dosage of Indinavir survival rates of hamsters diminished significantly.  Histology 
revealed that the drug caused serious perturbations in both cardiac and renal areas (Ramos-
Sanchez et al. 2014).   
Knowledge of the adverse effects of ART drugs is imperative to treatment planning and 
management of disease progression.  This is especially true since these adverse effects 
contribute significantly to non-adherence (Ammassari et al. 2001).  Especially in children, 
who initiate treatment soon after birth and will remain on ART life-long, it is important to 
study the long-term consequences of extended ART on neurodevelopment.  
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1.5   HIV-1 Infection in the Brain  
General neurodegeneration is a hallmark of HIV-1 infection in adults (Berger & Arendt 
2000).  In adults antiretroviral therapy has been shown to reverse neurodegeneration in the 
presence of HIV-1 infection as well as slow the progression to AIDS (Tamula et al. 2003).  By 
contrast, very little is known about the effects of ART and HIV on the developing brain.  An 
article reviewing all studies in Sub-Saharan Africa (SSA), evaluating as their primary outcomes 
development, cognition and behaviour in HIV-positive children, highlighted the paucity of 
data in this field (Abubakar et al. 2008).  Highly active antiretroviral therapy (HAART) 
improves some of the neurological pathology seen in HIV positive children (Laughton et al. 
2009).  However, most studies have been conducted in developed countries and the data is 
scarce for children living in SSA where the dominant genetic clade (and possible 
neurotoxicity) of the virus varies from that of North America (Abubakar et al. 2008; Hoare et 
al. 2012; Violari et al. 2008).  From the literature the patterns of CNS pathology in HIV-
infected children that have been highlighted previously are:   
 HIV related encephalopathy, both progressive and static.   
 HIV related CNS compromise, characterized by global cognitive functioning within 
normal limits, but with significant impairments in select neurodevelopmental functions.   
 Non-HIV related CNS impairment, which is related to these children’s complex medical 
histories (metabolic, endocrine, systemic illnesses, toxic side effects of drugs, secondary 
CNS infections)  




1.5.1   Neuropathogenesis of HIV-1 Infection 
HIV-1 invades the CNS early on in infection, usually within the first 10 days post-infection 
(Ivey, MacLean & Lackner 2009).   The predominant mechanism of invasion is via infected 
monocytes, macrophages and CD4+ T lymphocytes (Ivey, MacLean & Lackner 2009; van Rie 
et al. 2007).  In fact, M-tropic forms of HIV-1 tend to favour infecting the CNS (Aquaro et al. 
2002; van Rie et al. 2007).  Autopsied brain tissue showed that higher concentrations of HIV-
1 are found primarily in specific cells associated with CD4 and chemokine coreceptors (mainly 
CCR5 and CCR3) which are necessary for the progression of HIV-1 infection (Medders & Kaul 
2011; van Rie et al. 2007; Schnell et al. 2011; Wiley et al. 1986).  These cells include that of 
perivascular macrophages and microglia (Aquaro et al. 2002; van Rie et al. 2007; Wiley et al. 
1986).  It is also known that HIV-1 has a particular affinity for infection of astrocytes 
(Blumberg, Gelbard & Epstein 1994; van Rie et al. 2007; Tornatore et al. 1994).  Astrocytes 
are the most numerous of the glial cells in the CNS (Kandel, Schwartz & Jessell 2000).  They 
have a star-like shape with broad end-feet on their processes.  The projections with terminal 
end-feet projecting out from the main cell body centre, place the cell in contact with 
numerous other cells and structures, mainly capillaries and neurons (Kandel, Schwartz & 
Jessell 2000).   Astrocytes are thought to have a nutritive function, as well as playing an 
important role in forming the blood brain barrier (BBB) (Kandel, Schwartz & Jessell 2000).  
The BBB is an impermeable lining in the capillaries and venules of the brain that act to 
prevent toxic substances in the blood from entering the CNS.  Infection of astrocytes within 
the CNS may thus cause loss of supporting growth factors causing neuronal dysfunction, 
dysregulating the reuptake of neurotransmitters causing localised neurotoxicity, and 
loosening of the BBB permitting further seeding of HIV-1 and other opportunistic infections 
(Blumberg, Gelbard & Epstein 1994).  Blumberg and colleagues (1994) have proposed two 
main pathways causing neuronal damage during HIV-1 infection in children.  The first being 
widespread active and latent HIV-1 infection of astrocytes (Blumberg, Gelbard & Epstein 
1994).  The second major pathway is via HIV-1-infected macrophages.  These macrophages 
initiate inflammatory responses which are amplified through cell-cell interactions with 
astrocytes (Blumberg, Gelbard & Epstein 1994).  Macrophage-astrocyte interactions in the 
advent of HIV-1 infection produce arachidonic metabolites and potentially neurotoxic 
cytokines (TNF-α and IL-1β) (Blumberg, Gelbard & Epstein 1994).  These neurotoxic events 
thus lead to further astrocyte and macrophage activation and proliferation which expectedly 
amplifies these cellular processes (Blumberg, Gelbard & Epstein 1994).  Ultimately, the 
findings presented by Blumberg and colleagues (1994) are important as they show how a 
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small number of HIV-1 infected cells indirectly cause widespread tissue pathology.  This could 
in turn elicit profound neurological impairment.  The infection of glial cells within the CNS is 
of particular worry as certain viral proteins, pro-inflammatory cytokines and nitric oxide that 
are released by these infected cells could lead to neurotoxic events (Epstein & Gelbard 1999; 
van Rie et al. 2007).  It is hypothesized that fetal astrocytes as well as the developing CNS are 
particularly susceptible to perturbations in astrocyte function (van Rie et al. 2007).  This is 
the primary concern when dealing with perinatally infected children, as viral interactions on 
the glial cells may play a significant role in paediatric HIV-associated progressive 
encephalopathy.  While it is still not clear whether neurons are specifically infected by HIV, 
a study has shown some directly infected neurons in children, albeit a negligible number 
(Cantó-nogués et al. 2005).   
The unique CNS environment allows neurotropic HIV-1 to develop distinct genetic 
patterns characterized by their specificity in cell infection (Misra et al. 2003; Pillai et al. 2006).  
Genetic variation develops in the viral env, especially in gp120, which leads to changes in the 
CD4 binding domain, either by increasing the efficiency of gp120 and CD4 interaction or by 
increasing glycoprotein affinity for CCR5 (Salimi et al. 2013).  This is an important finding as 
it shows that due to the unique compartmentalization of the viral populations via the BBB 
we are faced with added problems of a possible unique genetic sequence, which may itself 
be drug resistant.  Genetic mutation allowing for compartmentalisations has been confirmed 
in adults by evidence of differences in HIV-1 genetic sequences or drug resistance via tests 
between blood and CSF (Lanier et al. 2001; Ritola et al. 2005; Strain et al. 2005).  Similar 
findings of unique viral populations in the CNS have also been reported in children (McCoig 
et al. 2002; van Rie et al. 2007).   
The effects of ART are hampered by the limited ability of the ARVs to pass the BBB; the 
variable perfusion of these drugs into the CNS could further result in drug resistant 
populations (Letendre et al. 2004; Yazdanian 1999).  Another concern is the longer lifespan 
of macrophages, microglia and astrocytes as compared to CD4 T-cells; this does not allow for 
swift eradication of infected cells and thus these unique viral populations would have a 
longer period to produce the virus, vRNA, and neurotoxic viral proteins (Env and Tat) (Aquaro 
et al. 2002; Medders & Kaul 2011; Perelson et al. 1997).   
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1.5.2   Progressive Encephalopathy  
“HIV-associated progressive encephalopathy of childhood” (HPE) is a term used to 
denote the clinical and pathological occurrence of progressive encephalopathy in children 
(Cantó-nogués et al. 2005; Rosenfeldt, Valerius & Paerregaard 2000).  The presentation of 
HPE is characterised by impaired brain growth, cognitive decline, and an overall dysfunction 
in global neurological abilities (Rosenfeldt, Valerius & Paerregaard 2000).  HPE progression 
is monitored by neurological tests, combined with computed tomography (CT) scanning or 
magnetic resonance imaging (MRI).  These techniques are also used to gauge the efficacy of 
certain drugs and ARTs.  Used as a clinical tool the researcher is able to test drug efficacy in 
hampering the progression of the encephalopathy (Johann-Liang et al. 1998; Rosenfeldt, 
Valerius & Paerregaard 2000).  MRI has been found to be more sensitive in exposing 
abnormalities of periventricular white matter than CT scans (Rosenfeldt, Valerius & 
Paerregaard 2000).  High viral load and low CD4 T-cell count has been linked to an increased 
risk of children presenting with HPE (Rosenfeldt, Valerius & Paerregaard 2000).  This said, in 
a study conducted on 128 perinatally HIV-infected children, 21% showed characteristic 
evidence of HIV infection induced encephalopathy despite at least 74% of children having 
viral load suppression at the time of diagnosis (Cooper et al. 1998).  Findings of viral load 
suppression in the systemic blood supply may not be representative of the 
compartmentalised and unique viral reservoirs in the CNS (Pillai et al. 2006; Strain et al. 
2005).  One need also understand that the findings of sometimes aggressive encephalopathy 
in children infected with HIV were gathered in a time where there were few ARTs available 
and little was known as to their effects on infants both pre- and post-natally (Johann-Liang 
et al. 1998).  Johann-Liang and colleagues (1998) performed neuroradiographic imaging in 
33 children infected with HIV.  They showed that apart from gross cerebral atrophy, there 
was also presence of calcification of the basal ganglia (Johann-Liang et al. 1998).  
Calcifications within the basal ganglia appear to be a common finding in HIV-1 infected 
children (Chiriboga et al. 2005; Epstein et al. 1986; Mitchell, Wendy 2001; Nozyce et al. 2006; 
Rosenfeldt, Valerius & Paerregaard 2000; Shah et al. 1996) and adults (Berger & Arendt 2000; 
McArthur, Brew & Nath 2005; Walot et al. 1996).   
Additional alterations that have been linked to HIV in children include  reactive gliolisis, 
neuronal loss, ventricular dilation, periventricular white matter abnormalities, as well as 
calcifications of other areas of the brain (Ernst, Chang & Arnold 2003; George et al. 2009; 
Johann-Liang et al. 1998; Rosenfeldt, Valerius & Paerregaard 2000).  Certain magnetic 
resonance spectroscopy (MRS) studies have indicated that glial cell activation in the white 
20 
matter and subcortical grey matter occurs early on in infection rather than immediate 
neuronal cell loss (Chang et al. 2002; Ernst, Chang & Arnold 2003).   
It has been suggested that the increased calcifications seen in some studies may have 
been as a result of increased viral load within the CNS (Rosenfeldt, Valerius & Paerregaard 
2000).  Combination therapy may be able to slow the encephalopathic progression due to 
the ability of the protease inhibitors to lower the viral load and increase the CD4 T-cell count 
(Bazzoli et al. 2010).  With the decreased viral load, it follows that the level of calcification as 
well as rate of global atrophy will decrease.   
1.5.3 Biomarkers Linked to HIV-1 Infection and ART Administration 
There is a need for objective biomarkers that diagnose and predict HIV-related brain 
disease.  Such biomarkers would contribute to individual treatment plans and drug trials.   
Autopsy Studies 
Findings via autopsy samples have shown significant localised differences of HIV-1 vRNA 
in various brain regions.  The caudate nucleus is one of the affected areas.  Given the 
caudate’s close proximity to the ventricles and thus CSF, it is particularly susceptible to HIV-
1 attack (McClernon et al. 2001).  McClernon (2001) observed individuals, all of whom on 
ART, experiencing high levels of dementia had presence of significantly higher VL within the 
CNS compared to mild to non-demented individuals; whilst no significant differences 
between their plasma viral loads were observed, peripherally.  This is in concordance with 
previous studies mentioning the unique compartmentalized nature of HIV infection in the 
CNS (Lanier et al. 2001; Ritola et al. 2005; Strain et al. 2005).  It was necessary to investigate 
such HIV-infected autopsy patients stereologically to gain insight into the relative volume 
and morphological changes that accompany HIV infection (Oster et al. 1993).  Since the study 
was of a formalin fixed cadaver sample and are representative of very sick subjects, findings 
may be biased.  The primary cause of death was pneumonia (84%).  Oster found that there 
was a vast increase in ventricular size of up to 55% in HIV-infected subjects compared to the 
controls.  Oster et al. also observed a global decrease in tissue mass in the HIV-infected 
individuals (Oster et al. 1993).  It was further identified that there was significant atrophy in 
central brain nuclei, mainly in the striatum and thalamus (Oster et al. 1993).  Eleven of 
nineteen (58%) had perturbations to glial cells, whilst seven (37%) had presence of reactive 
gliosis.   
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Adult Studies 
MRI and volumetric analysis has found a significant decrease in the volume of the basal 
ganglia in HIV-1 infected homosexual males with dementia as compared to those without 
dementia as well as HIV negative controls (Aylward et al. 1993).  This is a finding already well 
documented in adults (Becker et al. 2011; Cohen et al. 2010; Sarma et al. 2014).  Chiang and 
colleagues (2007) conducted a study on adults involving 26 HIV-1 infected individuals and 14 
HIV-1 seronegative controls.  Their study used 3D T1-weighted brain MR images and showed 
that even before the development of AIDS dementia or infections within the CNS, severe 
brain atrophy occurs within the corpus striatum, cingulate gyrus and callosal fibres, as well 
as other sensorimotor areas (Chiang et al. 2007).  Chiang et al. (2007) found that caudate 
atrophy was not readily detectable via tensor-based morphometry, however, detection and 
significance was found via surface-based anatomical modelling methods (Chiang et al. 2007).  
They attributed this discrepancy in findings to the lack of contrast between the caudate and 
surrounding tissue, making it difficult to profile the caudate accurately when using 
automated segmentation techniques (Chiang et al. 2007).  Arguably this study, as well as that 
of Aylward et al. (1993) and others, may contain a sample bias as the studies only included 
males (Aylward et al. 1993; Chiang et al. 2007).  However, the results may be applicable to 
the general population as, to date, no differences have been found in the progression of HIV 
in the CNS between males and females (McArthur 2004; Safriel et al. 2000; Xia et al. 2011).   
Along with the perturbations to deep grey matter structures, white matter has also been 
indicated to be affected by HIV infection (Andronikou et al. 2014; Chiang et al. 2007; Pomara 
et al. 2001; Thompson et al. 2006).  Thinning of the corpus callosum and ventricular 
expansion is associated with increased viral load (Thompson et al. 2006).  An increase in HIV-
1 vRNA within the CNS is associated with increased levels of HIV associated dementia 
(McClernon et al. 2001; Rosenfeldt, Valerius & Paerregaard 2000).  However, overall white 
matter thinning may not necessarily be as a direct result of viral load and may occur in 
response to grey matter damage, and thus neuronal cell death projecting from deep grey 
matter areas (Tate et al. 2011).   
Von Giesen and colleagues (2000) found, using MRI in conjunction with 
electrophysiological motor testing at the time of PET, that HIV-1 infected males receiving 
ART showed hypermetabolism in the basal ganglia.  The men had PVL ranging upward from 
undetectable levels to 30000 RNA/ml, with 6 of 19 (32%) having PVL above 1000 RNA/ml(von 
Giesen et al. 2000).  This finding could be due to the recruitment of glial cells to the site of 
the localised inflammatory response (Ernst, Chang & Arnold 2003; McClernon et al. 2001; 
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Sacktor et al. 2004; Silverstein & Kumar 2013).  The authors suggested a time course 
occurring in these adults, where, initially, hypermetabolism within the basal ganglia of these 
patients is associated with normal motor performance.  However, with time there is a shift 
to decreased motor performance once hypermetabolism converts to hypometabolism (von 
Giesen et al. 2000).  The more widespread the hypometabolism within the basal ganglia the 
more severe the deficit and pathologic slowing of motor performance.  Ernst and colleagues 
(2003) conducted similar research involving 14 HIV-1 positive males (age 37.8±7.1 years) 
using MRS and fMRI.  The mean PVL of the patients was 8318±20 RNA/ml.  The research 
indicated that increased concentrations of glial markers (choline-containing compounds, 
myo-inositol, and total creatine) in the frontal white matter and basal ganglia were 
associated with increased Blood-oxygen-level dependent (BOLD) activation during working 
memory tasks as compared to controls (Ernst et al., 2003).  These findings suggest that 
working memory deficits in HIV patients are modulated by inflammation occurring in the 
white matter and basal ganglia (Ernst, Chang & Arnold 2003).  Working memory deficits 
observed via Ernst et al. (2003) coupled with motor deficits observed by von Giesen, indicate 
pathology to the entire corpus striatum’s functional areas, in response to HIV infection.   
Chang and colleagues presented a study involving 18 seronegative controls and 24 HIV 
positive subjects.  Within the HIV-infected group, 12 were receiving ARV treatment with PVL 
<50 RNA/ml, whilst the 12 individuals not on treatment had PVL 28964±12009 RNA/ml 
(Chang et al. 2008).  Each participant performed a set of visual attention tasks with increasing 
load during fMRI.  Although the HIV-infected group showed greater load-dependent 
increases in brain activation than seronegative controls, subjects receiving ARV treatment 
had more activation in the bilateral superior frontal regions, compounded with a lower 
percent accuracy with increasing load (Chang et al. 2008).  Seronegative controls also showed 
less activation following repeated trials, whilst HIV positive individuals showed increased 
activation for repeated trials with increasing load.  Chang et al. (2008) thus concluded that 
ARV treatment may lead to higher neurocognitive recruitment and greater demand on the 
attentional network reserve, as well as less efficient usage of the neural networks and less 
practice effects.  The exhaustion of such reserve capacity in individuals receiving HAART 
would lead to additive decline in performance, compared to seronegative controls and those 
not receiving ART (Chang et al. 2008).  These findings are strongly contrasted by other adult 
studies reporting positive and sustained effect on neurocognitive impairment in the 
presence of HAART in adults (von Giesen et al. 2002; Tozzi et al. 1999).  i.e. VL suppression is 
associated with regression of neuropsychological test abnormalities (Tozzi et al. 1999). 
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Child Studies 
It is not clear whether the findings from adult studies can be extrapolated  to the 
developing brain of children.  There is little research that has actively followed and imaged a 
cohort of children stable on long term HAART since birth.  Most studies are of a cross-
sectional nature with small sample sizes, and large age ranges (Andronikou et al. 2014; Depas 
et al. 1995; von Giesen et al. 2003; Langerak et al. 2014; Sei et al. 1996; Tornatore et al. 
1994).  The atrophy and perturbations to brain tissue may correlate with the initial depletion 
of CD4 T-cells signifying that brain atrophy may accompany immunosuppression by HIV 
(Chiang et al. 2007; Rosca et al. 2011).  However, significant differences have been observed 
between CNS and plasma VL in previous studies; for example in a sample of vertically infected 
children (6 months to 18 years of age) disturbances to the CNS were associated with VL 
within the CSF but not with Plasma VL (McClernon et al. 2001; Sei et al. 1996).  Damage to 
the corpus striatum appears to occur despite treatment and is possibly related to the rate of 
initial insult, following initial penetration of HIV into the CNS (Andronikou et al. 2014; Becker 
et al. 2011).   
Anatomical changes that accompany development in healthy children are well 
documented (Bendersky et al. 2006; Caviness et al. 1996; Dowker 2006; Fan et al. 2011; 
Giedd et al. 1999; Rapoport et al. 2001).  Some studies that have attempted to conduct 
longitudinal research in HIV have not accurately described the effect of HAART given at or 
around birth (Koekkoek et al. 2006).  Although structural imaging studies of HIV-1 infected 
children are relatively scarce, one may expect that along with the global atrophy and 
encephalopathy observed in many HIV-1 infected children, some of the alterations in the 
subcortical brain structures observed in adults would also be found in children (Safriel et al. 
2000).   
One study took a unique approach looking at some pre-BBB manifestations of HIV 
infection in children (Shah et al. 1996).  Using MR images, CT scans, as well as autopsy 
findings, they showed that HIV-1 infected children had certain cerebrovascular abnormalities 
(Shah et al. 1996).  The abnormalities included subacute infarction, fusiform dilation in major 
vessels of the circle of Willis, as well as some other ischaemic lesions and arteriopathy (Shah 
et al. 1996).  This study, however, comprised only five individuals with ages spanning 9 to 18 
years, and thus carries little statistical power.  These pathological changes to the arterial 
supply and lining of vessels of the CNS may result in increased penetration of HIV through 
the BBB.   
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Using PET with 18F-labeled fluorodeoxyglucose in a group of 8 children (ranging from 
2.5 - 5.5 years of age) born to seropositive mothers and receiving AZT therapy it was found 
that diffuse hypometabolism and subcortical hypermetabolism was common to individuals 
with already severe neurological symptoms (n=3) (Depas et al. 1995).  Bilateral 
hypermetabolism was also present in the caudate nuclei of two children, as well as parietal 
hypermetabolism, while the lenticular nuclei were found to be abnormal in the same two 
children (Depas et al. 1995).  The study showed functional cerebral abnormalities in children 
without neurological signs, who also had normal morphological images (Depas et al. 1995).  
Therefore, functional cerebral abnormalities may precede the clinical and neurological signs 
and symptoms in the brains of HIV-1 infected children (Arendt et al. 1994; Depas et al. 1995; 
von Giesen et al. 2003; Sacktor et al. 1996).  Von Giesen et al. (2003) in a study of 17 HIV-
infected children (mean age 12.5±3.4 years, 12 vertically infected,14 receiving HAART, 10 
with PVL between 50 and 30000 RNA/ml)observed that CNS pathology in children is mainly 
centred on the basal ganglia, with major perturbations in cerebral white and deep grey 
matter (von Giesen et al. 2003).  Contrary to most findings observed in adults (von Giesen et 
al. 2002, 2003; Tozzi et al. 1999), motor performance is slowed leading to an increased 
recruitment of neural networks in children treated effectively with HAART (von Giesen et al. 
2003), a finding supported by Chang et al. (2008) in adults receiving ART.  A longitudinal study 
conducted on 34 children between 4 to 12 years of age (16 HAART naïve initiating HAART, 7 
HAART naïve not receiving treatment, and 11 who had already received treatment for over 
a year) (Koekkoek et al. 2006).  Psychomotor tests were administered 0, 4 and 12 months 
after enrolment.  Psychomotor performances were equal between groups at baseline and 
decreased significantly in the newly treated and untreated groups by 12 months (Koekkoek 
et al. 2006).  Although both groups showed decreased performance over time, the treated 
group had lower performance in shape tracking, finger tapping and reaction time.  Notably 
the newly treated group had significantly lower CD4% at baseline with high PVL, however all 
were stable and below 100 RNA/ml at 12 months, whilst untreated had VL between 1000 
and 31500 RNA/ml at 12 months.  This study raises questions as to the optimal timing of ART 
initiation and long-term effects of different treatment strategies.  To date, no studies have 
in a systematic way examined long-term effects of HIV and HAART in children, stable on ART, 
who initiated treatment at different times in infancy/early childhood.   
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1.5.4   Cognitive-Behavioural Biomarkers of Interest. 
Atrophy or pathology of the areas discussed above may result in associated 
neuropsychological impairment.  As stated, HIV dementia is one of the most frequently 
studied topics with regard to the effects of HIV on the brain (Aylward et al. 1993; Berger & 
Arendt 2000; Duyckaerts & Litvan 2008; McArthur 2004; Ritola et al. 2005; Sacktor et al. 
2004; Xia et al. 2011).  Since dementia is mainly linked to the formation and retrieval of 
memories, the limbic system is of special importance (Leon et al. 2001).  Studies of HIV 
encephalopathy in children show some surprising similarities as well as important 
differences with HIV-1 neuropathogenesis in adults.  It was reported that HIV-1 caused 
certain delays in neurological development because of calcifications and atrophy of brain 
areas.  Developmental deficits associated with HIV infection in children include impaired 
language and motor skills, cognitive deficits, impaired visuospatial integration ability, and 
impaired executive functions (Epstein et al. 1986; van Rie, Mupuala & Dow 2008), with the 
prevalence of functional deficits increasing with increasing age (van Rie et al. 2007).   
Findings regarding behavioural problems associated with HIV infection have been 
inconsistent.  Certain studies showed increased behavioural problems in HIV-infected 
children (Nozyce et al. 2006), whilst others documented decreased or equivalent behavioural 
problems in HIV-infected children compared to HIV-exposed, uninfected and control groups 
(Bachanas et al. 2001; Laughton et al. 2012; Mellins et al. 2003).  It has thus been 
hypothesised that behavioural problems may be as a result of biological or environmental 
factors as opposed to the direct influence of HIV infection (Mellins et al. 2003).   
Deficits in mental development present as a global cognitive deficit later on in infancy 
(Epstein et al. 1986; van Rie, Mupuala & Dow 2008).  The most strongly affected functional 
domains seem to be that of gross motor skill and function.  This is mainly seen when 
comparing HIV-infected with uninfected children (1 to 11years) (Abubakar et al. 2008; 
Epstein et al. 1986; Parks & Danoff 1999; Raskino et al. 1999; van Rie, Mupuala & Dow 2008).  
To date, no studies have systematically investigated differences in specific brain areas linked 
to cognitive impairments in children infected with HIV-1 (van Rie et al. 2007).  Poor language 
development, most notably deficits in expressive language, is the second most common 
finding in HIV-infected children (Wolters et al. 1997).   
Hyperreflexia and hypotonia have been widely reported (Bagenda et al. 2006; Govender 
et al. 2011; Laughton et al. 2012) and are both signs of a possible upper motor neuron 
(premotor) lesion (Kandel, Schwartz & Jessell 2000).  Upper motor neuron lesions can occur 
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in a number of motor pathways originating above the anterior horn of the spinal cord, within 
the CNS (Kandel, Schwartz & Jessell 2000, p. 600).   
Laughton and colleagues (2012) sought to investigate the possible neurodevelopmental 
effects of early antiretroviral therapy in infants.  The children were from the CHER trial; the 
same cohort from which the children in this study was derived.  The authors performed 
neurological examination and Griffiths Mental Development Scales (GMDS) on the children 
when they were between 10-16 months of age (Laughton et al. 2012).  The sample comprised 
26 ART deferred, 64 early ART, 28 HIV-exposed uninfected, and 34 HIV-unexposed uninfected 
children.  All GMDS scores were lower in the deferred treatment arm as compared to children 
who initiated ART early.  General Griffiths and Locomotor scores were significantly lower in 
the ART deferred group compared to early ART: GQ Score: mean(SD)=100.1(13.8) vs. 
106.3(10.6) p=0.02; and Locomotor score: 88.9(16.3) vs. 97.7(12.5), p<0.01, respectively.  
Early ART children performed as well as uninfected controls except in the Locomotor 
subscale.  The fact that early treatment as well as deferred treatment had lower scores 
compared to that of uninfected controls in Locomotor scores may be as a result of HAART 
itself and not merely HIV infection of the CNS alone (Chang et al. 2008; von Giesen et al. 
2003; Koekkoek et al. 2006).  It needs to be established whether scores for all subscales of 
HIV-infected as well as uninfected groups fell within the normal range on the GMDS 
(Laughton et al. 2012).  In 2013 Laughton and colleagues highlighted the lack of longitudinal 
studies of such perinatally infected children from birth through adolescent years (Laughton 
et al. 2013).   
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1.6 Standardising Terminology 
Terminology and definition of structures is important.  Certain atlases and texts avoid 
clarification of the nucleus accumbens, within the basal ganglia.  Certain texts include the 
cerebellum as part of the basal ganglia, however, negate the inclusion of the substantia nigra 
and subthalamic nuclei; often contradicting themselves mid-text (Joseph 2000).  In other 
texts the striatum is defined as including only the caudate and putamen (Netter 2002).  It is 
unclear in such texts whether the inclusion of the nucleus accumbens is inferred.  The term 
corpus striatum is used interchangeably with dorsal striatum, however the term ‘dorsal 
striatum’ does not include the nucleus accumbens which is part of the ventral striatum 
(Netter 2002).  Due to many incongruences and lack of standardisation, of both physiological 
and anatomical terms the definition of structures in this study are in line with that defined 
in:  
 Barr's The Human Nervous System: An Anatomical Viewpoint By John Kiernan, Raj
Rajakumar, 10th edition (Kiernan & Rajakumar 2013); and
 Principles of Neural Science By Eric Kandel, James H. Schwartz, and Thomas Jessell:
Chapter 43: The Basal Ganglia (DeLong 2000).
Figure 1.1 Hierarchical structure of the corpus striatum 
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The basal ganglia refers to a grouping of four subcortical grey matter nuclei, the 
striatum, globus pallidus, substantia nigra, the subthalamic nucleus (DeLong 2000).  These 
grey matter nuclei are highly connected to the cortex and subcortical motor areas forming 
complex pathways involved with movement, cognition, affect, motivation and procedural 
learning (DeLong 2000).   
The striatum comprises two main bodies, the caudate nucleus and putamen.  The ventral 
portion (ventral striatum) comprises the nucleus accumbens and olfactory tubercle.  The 
putamen coupled to the globus pallidus is known as the lentiform nucleus.  The addition of 
the globus pallidus to the striatum amends the terminology to corpus striatum (Also referred 
to as the striated body).   
The caudate nucleus lies superiorly to the thalamus and medially to the internal capsule.  
On the medial surface it is closely associated with the lateral ventricle as well as white matter 
tracts of the respective hemisphere.  Anteriorly the head of the caudate nucleus (the caudate 
head referred to from here as the caudate (Cd)) is well defined and protuberant.  The caudate 
nucleus begins to taper off gradually as it is viewed posteriorly, this region is known as the 
caudate tail.  The caudate tail terminates in the amygdala.   
Together the putamen (Pu) and globus pallidus (GP) form the lenticular nucleus(LN) 
(Otherwise known as the Lentiform nucleus).  The LN is bound laterally by the external 
capsule and medially by the thalamus and caudate nucleus.  Its most antero-medial surface 
is continuous with the infero-lateral portion of the nucleus accumbens.   
The caudate nucleus, Pu, and GP play a role in the planning and modulation of 
movement pathways.  Most findings in the literature have highlighted locomotor deficits in 
perinatally HIV-infected children (Bagenda et al. 2006; von Giesen et al. 2003; Govender et 
al. 2011; Laughton et al. 2009, 2013).   
The nucleus accumbens (NA) lies anteriorly to the amygdala and inferiorly to the caudate 
nucleus.  The caudate is continuous anteriorly and has projections to and from the nucleus 
accumbens, which in turn is fused to the inferior portion of the putamen.  The NA is a part 
of the mesolimbic dopamine pathway.  It is activated in the presence of a reward and in turn 
transmits signals to the cortex to acknowledge the incentive; further stimuli are directed to 
the GP and orbitofrontal cortex eliciting a pleasurable response.  This area is thought to be 
responsible for goal-related activities, and plays an important role in both learning and 
addiction (Bernier, Whitaker & Morikawa 2011; Berridge 2007; Doya 2000).   
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The corpus callosum (CC) is the major inter-hemispheric connection.  It consists of a 
wide, flat bundle of neural fibres (axons) located in the midline at the longitudinal fissure 
(Kandel, Schwartz & Jessell 2000).  It connects and allows communication between the left 
and right cerebral hemispheres, via callosal fibres.   
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1.7 Manual versus Automated Segmentation 
For an accurate study of the effects of pathology on the brain, a large cohort of autopsy 
patients would be ideal, however when dealing with HIV-1 infection in children, death caused 
by opportunistic co-infections is a definite confounding factor (Wrzolek et al. 1995).  
Neuroimaging via MRI is non-invasive.  As such, MRI is a solution to viewing the brain of 
individuals, as opposed to exploratory surgery, which is impossible when dealing with a living 
individual (Morey et al. 2009).  In light of the above, MRI in conjunction with manual 
segmentation remains the gold standard in estimating the volumes of brain regions (Barnes 
et al. 2008; Boccardi et al. 2011; Dewey et al. 2010; Hasan & Pedraza 2009; Morey et al. 2009; 
Sánchez-Benavides et al. 2010; Tae et al. 2008).   
As image acquisition has become faster, cheaper and more detailed, the need for 
answers to pertinent questions, involving the brain and the effects of various pathologies on 
the brain, has become more apparent.  As such, large databases of MR images are being 
accumulated at a hurried rate.  The accumulation of such large databases allows more 
researchers to delve into quantitative assessments to examine subtle relationships between 
various brain areas and disease progression, efficacy of treatment regimens, and other 
factors that may not have been able to be distinguished in smaller samples (Morey et al. 
2009; Powell et al. 2008).  Manual tracing has been an excellent mode of investigation, 
however, as the size of datasets has increased the demand on the individual, tracing by hand, 
as well as the labour cost to the research team has increased to the point where it is no 
longer a feasible option.  With the advent of automated segmentation techniques and fast 
developing improvements to their accuracy, manual tracing has evolved into a tool to test 
the reliability of automated techniques, on a small subset of the sample in question, rather 
than the primary mode of investigation.   
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1.7.1   Shortcomings of Manual segmentation 
Albeit the preferred more accurate mode, manual tracing is thwarted with 
shortcomings.  The first major drawback, alluded to before, is time.  An experienced 
neuroanatomist may require two hours to trace the Pu and GP, and up to ten hours to trace 
all structures within the basal ganglia, for a single dataset.  Even an experienced individual 
would find it an extremely taxing experience (physically) to spend such extended periods of 
time in front of a backlit display.  To counteract this issue, one could employ more 
researchers to trace the regions of Interest (ROIs), dividing the workload.  However, 
differences in knowledge between researchers regarding borders of ROIs and subtle 
differences in subjective thinking (and thus judgement calls for approximate borders of ROIs) 
may lead to systematically different volume estimates (Morey et al. 2009).  Thus, the highest 
consistency and reliability is achieved by employing a single researcher to delineate all ROIs 
within a dataset (Morey et al. 2009).  To combat this problem, training would need to be 
established for all manual tracers.  Although costly and time consuming, this would occur 
where the primary researcher has sessions with fellow researchers and guides them through 
the tracing protocol for each ROI, slice-by-slice, for a number of scanned participants, such 
that judgement calls and criteria for borders of ROIs are more standardised and established.  
Even veteran experts introduce inter-rater and intra-rater variability via criteria drift and 
bias to the manual outlines which are suggested to be absent in automated computer 
generated techniques (Boccardi et al. 2011; Mulder et al. 2014; Powell et al. 2008).  That 
being said, inter-rater reliabilities via retracing a subset of the sample by an independent 
tracer is often employed to gauge the reliability of the single rater.  Intra-rater reliabilities 
are obtained by retracing a subset of images at a later time.   
As a result of the shortcomings listed above automated segmentation and parcellation 
has gained substantial attention over the past few years.  Automated techniques provide 
fairly consistent repeatable results (Morey et al. 2009).  Updated software and 
improvements to segmentation and parcellation algorithms, as well as improvements to 
atlases are readily accommodated (Han & Fischl 2007; Morey et al. 2009).   
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1.7.2 Automated Segmentation using FreeSurfer 
During automatic subcortical segmentation, each voxel in the normalized brain volume 
is assigned one of about 40 labels.  Automatic subcortical segmentation (aseg) of a brain 
volume is based upon an atlas containing probabilistic information on the location of 
structures (Fischl et al. 2002).  The atlas was generated from a large training set of manually 
traced measurements (Fischl et al. 2002).  The automatic subcortical segmentation can take 
over 11 hours to complete 
(http://ftp.nmr.mgh.harvard.edu/fswiki/SubcorticalSegmentation).   
As stated before, it was suggested that inter-rater and intra-rater variability and bias 
may be absent in automated computer generated techniques (Boccardi et al. 2011; Mulder 
et al. 2014).  However, a paper published in 2012  shed light on some factors that may 
contribute to varying results obtained via the FreeSurfer software (Gronenschild et al. 2012). 
In the results of segmented volumes gathered from a group of 30 T1-weighted 3T MRI scans 
the group showed significantly different results between FreeSurfer version, as well as 
between type and version of operating system and workstation specifications (Gronenschild 
et al. 2012).  Another two variables which may affect the accuracy of segmentation 
techniques, are datasets that originate from either a different scanner platform or pulse 
sequence than that of the original dataset from which the training atlas was derived (Han & 
Fischl 2007).  This could relate to MR scanners of different make or model, or even the same 
scanner from which the original dataset was acquired that has had software or hardware 
upgrades.  As international collaboration and multicenter clinical research has become easier 
with the advent of high bandwidth internet and cloud-based datasets archiving the need for 
standardised outputs has become a necessity (Han & Fischl 2007).  Not all research groups 
or hospitals would have a standardised MR scanner platform.  However, some investigators 
have addressed this problem by introducing an intensity renormalization procedure that 
automatically adjusts the atlas intensity model (derived from the training set of manually 
traced measurements) to new input data (Han & Fischl 2007).  The new procedure was tested 
using 27 subjects.  The results indicated little to no effect on the performance of automated 
segmentation, if no contrast change was expected.  However, average Dice coefficients 
improved by over 10% for numerous structures, compared to the non-renormalized model, 
when data was gathered via a different scanner platform (Han & Fischl 2007).  This approach 
caters for data acquired across different scanner platforms, as well as rendering the tools 
largely insensitive to scanner upgrades and variations in pulse parameters (Han & Fischl 
2007).   
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Regardless of numerous sophisticated software packages, with algorithms capable of 
powerful automated segmentation, there is still a lack of comprehensive published research 
comparing automated software to manual tracing (Barnes et al. 2008; Dewey et al. 2010; 
Morey et al. 2009; Powell et al. 2008).  That being said, certain investigators have sought to 
gauge the efficacy of various modes of segmentation techniques.  Not only did they 
investigate the similarity of the volumetric measurements, but they also investigated their 
reliability in highlighting the effects of certain pathologies on the brain (Dewey et al. 2010; 
Hsu et al. 2002; Morey et al. 2009; Tae et al. 2008).  To gauge the efficacy of certain atlases, 
as well as segmentation software, researchers often opt for areas such as the hippocampus 
or amygdala (Barnes et al. 2008; Hsu et al. 2002; Morey et al. 2009; Mulder et al. 2014; 
Sánchez-Benavides et al. 2010; Tae et al. 2008).  These structures bear large contrast and are 
already easily distinguishable compared to surrounding tissues.   
1.7.3   Comparison of Segmentation Techniques in HIV Cohorts 
The only comprehensive study on an HIV cohort (n=120; mean age 47.3±7.2 yrs) and the 
efficacy of various segmentation techniques was performed by Dewey et al. (2010).  They 
too highlighted the vastness of literature pertaining to testing the reliability of automated 
segmented volume versus manual tracing of the hippocampus and relative scarcity of 
research pertaining to other subcortical structures (Dewey et al. 2010).  They compared 
three segmentation techniques, two automated software packages and one auto-assisted 
manual (AAM) measurement, to gauge the accuracy and consistency of the techniques.  The 
automated software used were FreeSurfer and Individual Brain Atlases using Statistical 
Parametric Mapping (IBASPM).  Their AAM measurements were acquired from a customised 
version of the FreeSurfer software and via manually correcting the outputs (Dewey et al. 
2010).  The main reasoning behind the usage of an auto-assisted technique was to save time, 
as exclusive manual tracing is exceptionally time consuming (Dewey et al. 2010).  The use of 
AAM to gauge accuracy and consistency could arguably introduce bias to analyses, as 
correlations with the FreeSurfer software would naturally be higher, as was found to be the 
case, as the AAM technique is derived from the FreeSurfer software and atlases.  Following 
manual correction, the volumes gained are not entirely mutually exclusive from the 
automated FreeSurfer derived volumes and the results of this process may be somewhat 
confounded.  Dewey and colleagues addressed this issue by manually tracing a subset of 
their sample and correlating the manually segmented volumes with that of the AAM 
measurements (Dewey et al. 2010).  They observed an extremely strong correlation between 
manual and AAM techniques in all structures measured (Cronbach’s α>0.90) (Dewey et al. 
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2010).  A significant Cronbach’s α>0.90 falls within the range of what can be expected when 
correlating inter-rater reliabilities between manual tracers (Dewey et al. 2010; Morey et al. 
2009; Tae et al. 2008).   
There is very little literature pertaining to the reliability of automated segmentation in 
the developing brain, let alone the efficacy of these techniques in the developing brain with 
presence of pathology.   
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1.8 Research Aims and Objectives 
1.8.1 Selection of Regions of Interest 
As reported the basal ganglia and surrounding structures are of particular interest when 
studying the effects of HIV-1 infection on the brain.  Previous studies have revealed 
calcifications, abnormalities in metabolism and function of the basal ganglia in both children 
and adults.  Perturbations in white matter have also been found, specifically in the corpus 
callosum of HIV-1 infected children.  In this study, we have chosen to examine brain volumes 
in areas that relate to specific functional and cognitive domains where impairment has been 
reported, specifically with regard to functional deficits reported in the CHER cohort 
(Laughton et al. 2012).   
1.8.2  Aims: 
The primary aim of this study is to assess differences in the volumes of selected regions 
of interest in the developing brain of 5-year old children, with HIV and receiving HAART 
compared to uninfected controls, using high-resolution structural MRI and manual tracing.  
Results from manual tracing will be compared with findings from automated segmentation 
using FreeSurfer.   
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CHAPTER 2 MATERIALS AND METHODS 
2.1 Study Participants 
This study included fifty-one 5 year old children from the Children with HIV Early 
Antiretroviral Therapy (CHER) trial (Cotton et al. 2013) and 30 uninfected control children 
who were either recruited specifically for this study (n=6) or from an interlinking vaccine trial 
(n=24).  
Children with HIV-1 infection belonged to one of three treatment arms: ART-Def (ART 
was deferred unless CD4% < 25% in first year or CD4% < 20% from second year onwards, or 
if a selection of other immunological/clinical criteria presented), ART-40W (ART initiated 
immediately and interrupted after 40 weeks), and ART-96W (ART initiated immediately and 
interrupted after 96 weeks) (Cotton et al. 2013). 
2.2 Data Collection and Data Transformation 
2.2.1 Neuroimaging Protocol 
All children received MRI scanning on a 3T Allegra MRI (Siemens, Erlangen, Germany) at 
the Cape Universities Brain Imaging Centre (CUBIC) according to protocols that had been 
approved by the Human Research Ethics Committees of the Universities of Cape Town and 
Stellenbosch.  All parents provided written informed consent and all children provided oral 
assent.  
High-resolution T1 weighted images were acquired using a volumetric echo-planar 
imaging (EPI) navigated (Tisdall et al. 2012) multi echo magnetization prepared rapid 
gradient echo (MEMPRAGE) sequence (van der Kouwe et al. 2008)  Imaging parameters 
were: FOV: 224 x 224 mm2; 144 sagittal slices, TR: 2530 ms; TE: 1.53/3.19/4.86/6.53 ms; TI: 
1160 ms; Flip angle: 7°; voxel size: 1.3 x 1.0 x 1.0 mm3, scan time 5:20.  The 3D EPI navigator 
provided real-time motion tracking and correction which served to substantially reduce the 
presence of any motion artefacts in the structural imaging data, despite significant subject 
motion. 
Data of three uninfected control children were excluded from the analyses: two due to 
incomplete scanning data and poor image quality; one due to the presence of pathology.  As 
such, scans for 78 children (51 HIV-1 infected/27 uninfected controls; 11 Cape Coloured/67 
Xhosa) were traced.   
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2.2.2 Data Pre-processing 
Each subject had a pre-assigned participant ID to ensure anonymity.  Each scan’s DICOM 
files were manually transformed into the AC-PC plane and rotated for hemispherical 
symmetry using BrainVoyager QX software (Brain Innovation, Maastricht).  The DICOM files 
were exported in analyse format (*.img; *.hdr).  
2.2.3 Manual Tracing Protocol 
Summary of the Manual Tracing Protocol 
All structures were manually traced using MultiTracer software 
(http://bishopw.loni.ucla.edu/MultiTracer/) on a Lenovo ThinkPad X200 tablet and 
integrated active digitizer stylus.  Dr Christopher Warton, a neuroanatomist from the 
Department of Human Biology at the University of Cape Town developed the protocol used 
to trace and delineate the structures of interest.   
All tracings were performed at 4X magnification.  Magnifications greater than this 
resulted in visible pixelation of the images.  In Multitracer software it is possible to adjust the 
contrast and brightness (Woods 2005).  The contrast is adjusted by manipulating a threshold 
value where any pixels with image intensity values below a chosen threshold appear black 
(Woods 2005).  The range of prescribed voxel intensities range from 0 to 65535 pixel intensity 
units (PIU) in the Multitracer software (Woods 2005).  Image files loaded into the program 
are scaled accordingly to fit this pixel intensity range (Woods 2005).  The contrast used in 
this study ranged from PIU of 13000 to 18000 depending on the structures measured.  Screen 
brightness for the tracing tablet was set to 100%.  Brightness of images loaded into the 
software was set to 1.34  (49% of a maximum unadjusted default scale value of 2.72) for 
most structures, however adjusted accordingly depending on structures of interest and 
ambient lighting (Woods 2005).   
MultiTracer allows one to trace the brain structure in each of the three orthogonal 
planes: sagittal, horizontal and coronal.  The tracings of selected brain structures were 
completed by manually outlining the structures on MR images, slice by slice.  Once the 
subcortical structures were fully outlined in the respective plane for multiple contiguous 
slices, MultiTracer software computes the area of the contour on each slice and calculates 
the overall volume of the structure.  The frust volumes calculated by MultiTracer were used 
in the present study.  Frust volume is calculated by assuming that the structure extends from 
the centre of the first plane on which it was drawn to the centre of the last plane on which 
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it was drawn with the square root of areas varying linearly when moving from the centre of 
one plane to the centre of the next (Woods 2005).  For standardisation purposes, tracing of 
all subcortical grey matter structures were performed in the coronal plane.  Other planes 
(sagittal or horizontal) were employed as reference planes assisting with tracing in the 
primary plane.  Contours created in other planes appear as a formation of dots forming the 
outline of the structure in the primary plane.  These reference points aided tracing of the 
contour in the primary plane.   
Reliability of Manual Segmentation 
Inter-rater and intra-rater reliabilities were assessed for each structure using 
independent measurements for 10 participants who were randomly selected by an expert 
neuroanatomist and primary researcher, respectively, and assessed via Pearson and intra-
class correlation.   
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2.2.4 Specific Tracing Protocol for Regions of Interest 
Due to its frequency in the HIV literature, the basal ganglia was the primary subcortical 
region of interest (ROI).  All grey matter structures within the basal ganglia were traced, with 
the exception of the substantia nigra and subthalamic nuclei.   
Caudate and Nucleus accumbens 
Both the caudate and nucleus accumbens were traced in the coronal view.  Contrast was 
set so that PIU less than 13000 appeared as black and brightness to 1.34.   
The caudate was traced from the anterior tip of the structure moving posteriorly.  The 
caudate gradually decreases in size to the point where it becomes indistinguishable from 
surrounding tissues at the posterior end and curves infero-posteriorly toward the thalamus. 
We completed the tracing for this structure at this point.  It is important to note that the 
caudate is continuous anteriorly and has projections to and from the nucleus accumbens, 
which in turn is fused to the inferior portion of the putamen.  The exact borders between 
these aforementioned structures are not clearly defined on MR images.  The true borders of 
these structures can only truly be found cytoarchitectonically.  It is for this reason that both 
the caudate (caudate head) and nucleus accumbens were initially traced as a single unit.  The 
lateral border of the nucleus accumbens associated with the putamen was demarcated by a 
single vertical line (in each slice) arising from the inferior border of the lateral limb of the 





Figure 2.1 Coronal view of an MRI scan showing the four different structures that were traced in the 
right basal ganglia  
40 
the full structure was calculated including both the caudate and the nucleus accumbens. 
Subsequently, the nucleus accumbens was partitioned away and removed from the current 
trace.  This was achieved by an oblique line (in all slices) from the inferior limb of the lateral 
ventricle to the inferior border of the internal capsule.  The new volume thus derived was 
that of the caudate alone, while the difference between the two measurements was that of 
the nucleus accumbens.   
Putamen and Globus pallidus 
Both the putamen and globus pallidus were traced in the coronal view.  Contrast was 
set so that PIU less than 18000PIU appeared as black and brightness to 1.34.  The junction 
between the putamen and globus pallidus is readily seen in the horizontal plane.  A few 
traces in the horizontal plane acted as reference to the borders between the two structures 
when tracing in the coronal plane.  The coronal plane is still the optimal plane for 
measurement as it allows one to distinguish superior and inferior borders of both structures 
from surrounding tissues.  Much like the caudate and nucleus accumbens, both structures 
were traced as a single entity.  The volume for the combined structure was calculated.  The 
globus pallidus was then partitioned away and removed.  This was done by making use of 
the reference points created in the horizontal plane and drawing a line (in each slice) 
following the reference points along the medial border of the putamen.  The volume for the 
new structure would thus be that of the putamen alone.  The difference between the 
volumes of the two structures is that of the globus pallidus.   
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Corpus Callosum 
The corpus callosum was traced in the sagittal view.  Contrast was set so that PIU less 
than 13000PIU appeared as black and brightness adjusted accordingly to optimally highlight 
the structure of interest.  The blood vessel indicated with a green arrow (Fig2.2) often 
occluded the view of the corpus callosum and thus frequent adjustment of the brightness 
was necessary to adequately view the structure.   
The tracing of the corpus callosum involved finding the midline of the subject’s brain, in 
the sagittal plane.  As the MRI scans were AC-PC transformed and rotated, the midline often 
fell between the middle few slices of the scan (approximately slice 128/256).  The exact 
midline was found by visually inspecting slices adjacent to slice 128 in order to identify the 
slice where the thalamus appeared to be the smallest in size.  This midpoint of the thalamus 
marks the midline of the midbrain and is known as the massa intermedia.  The corpus 
callosum was then traced in adjacent slices, either side of the midline, in the sagittal plane.  
The volume of a single slice was calculated by dividing the volume for both slices by the 
number of slices traced (two).   
Figure 2.2 Sagittal view of an MRI scan showing the corpus callosum in yellow 
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2.2.5 Automated Volumetric Measurements 
Brains of each subject were automatically segmented by an independent researcher into 
cortical and subcortical regions using FreeSurfer software 
(http://surfer.nmr.mgh.harvard.edu/).  The atlas used in this study was aseg+aparc a2009.  
The outcome of the segmentation process is a labelled volume comprising 175 white matter 
(WM), grey matter (GM) and cerebrospinal fluid (CSF) regions.  Segmentations were checked 
for errors and manually corrected where needed, after which automatic reconstruction was 
repeated.  This process was repeated in an iterative way. 
2.3 Data handling and Statistical Analyses 
The primary researcher was blinded to all participant demographic data and automated 
results pending the completion of manual tracing.   
Statistical analyses were managed and performed in Statistica 11 (StatSoft Inc. 2012) 
and IBM SPSS Statistics 22 (IBM Corp. 2013).  Descriptive statistics were compiled for all 
variables.  A Shapiro-Wilk test was used to test for normality of continuous variables (Shapiro 
& Wilk 1965).  Appropriate results were displayed and relevant tests performed depending 
whether the variables in question were parametric or nonparametric.  The Grubbs’ Test was 
used to test for any possible outliers in the sample (Grubbs 1969).   
2.3.1 Standardization for Brain Size 
A reduction of total brain size and underlying structure, as a result of HIV-1 infection has 
been reported in adults (von Giesen et al. 2000; Lawrence & Major 2002).  Thus, controlling 
and standardising for total brain size in adults may be necessary.  Over and above the 
expected global atrophy, resultant from HIV-1 infection, controlling for brain size would 
allow one to determine pathology.  In children it is uncertain whether global atrophy or 
hypertrophy would be expected.  As such, structural volumes were not normalised for total 
brain volume in this study.  
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2.3.2 Testing for Confounders 
Sex, age at scan, birthweight, and ethnicity were investigated as possible confounders 
of the effects of HIV and ART on brain volumes.  Possible sampling bias was investigated.   
 Categorical Confounders 
A Chi squared test was used to examine associations within categorical confounding 
variables (sex and ethnicity) and their distribution across treatment groups.  Univariate 
analysis of variance (ANOVA) was performed to test for possible volumetric differences 
resulting from the potential confounding effects of each categorical confounding factor.   
 Continuous Confounders 
The association of continuous variables (age at scan and birthweight) were examined via 
univariate ANOVA to assess differences in the means between treatment groups.  A Pearson 
or Spearman rank ordered correlation was used to test the correlation of continuous 
variables with structural volumes.    
 Subset Removal 
Ethnicity was found to be a major confounding factor (Appendix A).  Significant volume 
differences between Xhosa and Cape Coloured individuals were observed.  The distribution 
of children across treatment groups were also found to be not well matched within the Cape 
Coloured group.  As such, the Cape Coloured subset (n=11) was removed from the sample, 
leaving 67 Xhosa children (49 HIV-1 infected and 18 uninfected controls).   
Five HIV-1 infected children were symptomatic at the time of enrolment and required 
immediate therapy.  These children were not randomized into treatment groups.  These too 
were excluded from further analyses, leaving 62 Xhosa children (44 HIV-1 infected and 18 
uninfected controls).   
Analyses for the remaining confounders (sex, age at scan and birthweight) were 
recalculated for the remaining children. 
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2.3.3 Hypothesis Testing:  Structural Volumes between Groups 
Univariate analysis of variance (ANOVA) was used to test for any significant differences 
between the structural volumes of diagnostic groups (HIV-1 infected versus uninfected 
controls) and treatment groups (ART-Def vs ART-40W vs ART-96W vs uninfected controls).  
For a single categorical variable comparing more than two factors but less than four a Fisher’s 
Least Significant Difference test (LSD) was used for post-hoc analyses.   
Analysis of covariance (ANCOVA) was performed to control for effects of covariates 
found to have significant association with structural volumes (sex and age at scan).   
2.3.4 Hypothesis Testing: Structural Volume across Clinical Measures 
Associations of structural volumes with clinical continuous variables were assessed using 
Pearson or Spearman rank ordered correlations amongst infected children only.  If a 
continuous independent variable was found to be not normally distributed, a Spearman Rank 
ordered correlation was used to test for a significant relationship between the predictor 
variable and the structural volumes of the areas measured.   
Plasma Viral Load (PVL) values for 2 time points (enrolment and prescan) were 
transformed into categorical variables, with values below 399 copies RNA/mL denoted as 
suppressed “Suppressed”, 400-750 000 copies RNA/mL as “Low”, and greater than 750 001 
as “High”.   
Associations of structural volumes with CD4+ percentage (CD4%) was investigated at 3 
time points (enrolment, prescan and nadir), as a continuous variable, using Pearson 
correlation.  As in the original CHER study (Cotton et al. 2013; Violari et al. 2008) on HIV-1 
infection and effects of treatment outcomes of HAART, where a CD4% of less than 25% was 
considered immunocompromised and a CD4% greater than 25% as being within the normal 
range.   
CD4/CD8 ratio was investigated in a similar way.  Values less than 1 were considered 
immunocompromised, greater than 1 as healthy, and values greater than 2 indicated a 
strong immune system.   Nadir CD4/CD8 ratio was not available for analyses.  Associations 
of structural volumes with CD4/CD8 ratio and CD4% were compared and the variable most 
strongly related to volume was noted.    
As no clinical data was available for the control group, a Factorial ANOVA could not be 
performed.   
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2.3.5 Regression Analyses 
Covariates of sex and age at time of scanning were investigated for possible associations 
with volume, for each structure.  Only covariates found to be weakly related (p<0.1) to 
volume were retained in the regression model.   
The Bonferroni method was used to correct for multiple comparisons testing and 
possible Type I error.  The Bonferroni adjusted P-values were generated by dividing 0.05 by 
the number of permutations present in each set of analyses.   
(Eg. Adjusted 𝑃 cut off =
0.05
(Number of structures analyzed)×(Number of independent variables)
2.3.6 Hypothesis Testing:  Manual versus Automated Measures 
The Bland-Altman method for testing agreement between measures was used.  A one-
sample t-test was used to examine differences between the mean difference (automated 
volume deducted from manual volume) of structural volumes of manually traced structures 
compared to that of the automated FreeSurfer derived volumes, and how far they deviated 
from 0mm3.  Pearson and intraclass correlations were performed to show to what degree 
the automated measures accurately described the variability seen in manual tracing 
measures.   
Finally, a univariate ANOVA was computed to assess volumetric difference using 
automated measures between HIV-1 infected and uninfected controls for each structure.  
This was to gauge the relative efficacy of automated measures in detecting possible 
pathology, and to assess agreement with results from manual segmentation analyses.   
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CHAPTER 3 RESULTS 
3.1 Sample Characteristics 
We present data for 62 Xhosa children (mean age ± s.e. = 5.43 ± 0.04; 25 male) 
comprising 18 uninfected controls, 17 ART-Def, 14 ART-40W, and 13 ART-96W.  Sample 
characteristics are summarised in Table 3.1.  
Demographic variables did not differ between groups except that uninfected children 
were slightly older than infected children.  However, the age range of HIV-1 infected children 
fell within the range of uninfected controls.  Although there was no significant sex difference 
between groups, the ART-40W group did have fewer males than all the other groups. 
Table 3.1  Sample Demographics 
 ᵡ2 
F p -value
Sex: Male n(%) 8 (44%) 7 (41%) 4 (29%) 6 (46%) 25 (40%) 1.12 0.77
Age at Scan [Yrs]1 Mean(SD) 5.6 (0.5) 5.3 (0.3) 5.4 (0.2) 5.4 (0.3) 5.4 (0.3) 3.05 0.04
(Range)
Birth weight [g]  Mean(SD) 3104 (641) 3126 (352) 3136 (462) 2999 (447) 3092 (483) 0.04 0.99
1 p <0.05
p <0.1
Values are Mean (SD), Range, or number(%) where specified.  
Chi 2 for categorical Associations F  statistic from Univariate ANOVA for parametric data. 



















3.2 Reliability of Manual Segmentation 
Table 3.2 shows inter- and intra-rater ICC, as well as Pearson’s correlation, in each 
structure for a random selection of 10 brains that were retraced by an independent or the 
same observer, respectively.   
All inter-rater Pearson correlations were highly significant and ranged from r=0.71 for 
the left caudate to r=0.93 for the corpus callosum.  Cronbach’s α’s were above 0.8 in all 
regions.   
In all regions, intra-rater Pearson correlations were greater than r=0.82, and Cronbach’s 
α’s were all above 0.83.   











Coeffiecient 0.78 0.86 0.99 0.99
p -Value 0.007 <0.001
Coeffiecient 0.72 0.84 0.98 0.99
p -Value 0.019 <0.001
Coeffiecient 0.71 0.83 0.99 0.99
p -Value 0.020 <0.001
Coeffiecient 0.74 0.85 0.98 0.99
p -Value 0.015 <0.001
Coeffiecient 0.78 0.87 0.95 0.96
p -Value 0.008 <0.001
Coeffiecient 0.86 0.90 0.82 0.83
p -Value 0.001 0.003
Coeffiecient 0.93 0.94 0.89 0.94
p -Value <0.001 0.001
Coeffiecient 0.89 0.88 0.98 0.99
p -Value 0.001 <0.001
Coeffiecient 0.8 0.86 0.99 0.99
p -Value 0.006 <0.001
Coeffiecient 0.86 0.89 0.98 0.99
p -Value 0.001 <0.001
Coeffiecient 0.77 0.85 0.98 0.93
p -Value 0.009 <0.001
Coeffiecient 0.78 0.80 0.88 0.93
p -Value 0.008 0.001
Coeffiecient 0.75 0.84 0.93 0.96

















3.3 Structural volumes between HIV-infected and 
uninfected children 
Table 3.3 shows a comparison of structural volumes between uninfected and infected 
children both before and after controlling for potential confounders.  Table 3.4 shows 
relations between volumes and potential confounders – sex, birthweight and age at scan.   
ROI r p-value r p-value r p-value
L Caudate+NA -0.24 0.064 0.06 0.659 -0.08 0.518
R Caudate+NA -0.24 0.064 0.08 0.555 -0.10 0.450
L Caudate -0.24 0.061 0.08 0.545 -0.09 0.480
R Caudate -0.25 0.052 0.09 0.478 -0.12 0.334
L NA -0.10 0.431 -0.05 0.713 -0.01 0.928
R NA -0.04 0.746 -0.03 0.808 0.07 0.600
CC -0.11 0.391 0.17 0.174 0.25 0.050
L Pu + GP -0.31 0.015 0.02 0.894 -0.02 0.883
R Pu + GP -0.23 0.070 -0.01 0.960 0.02 0.885
L Pu -0.30 0.018 0.02 0.853 0.04 0.781
R Pu -0.17 0.176 -0.02 0.879 0.05 0.706
L GP -0.24 0.059 -0.01 0.960 -0.17 0.194
R GP -0.34 0.008 0.03 0.818 -0.07 0.615
Sex Birthweight Age at Scan
Table 3.4  Relations of structural volumes with sex, birthweight and age at scanning 
Table 3.3 Comparison of structural volumes by diagnosis 
Mean (SD) Mean (SD)
L Caudate + NA 4564 (619) 4650 (472) 0.350 0.56 0.230 0.63
R Caudate + NA 4772 (583) 4867 (448) 0.486 0.49 0.305 0.58
L Caudate 4045 (551) 4060 (416) 0.014 0.91 0.003 0.95
R Caudate 4216 (527) 4247 (415) 0.061 0.81 0.000 0.99
L NA 520 (124) 591 (128) 3.951 0.05 4.486 0.04
R NA 556 (107) 621 (117) 4.122 0.05 5.750 0.02
CC 470 (71) 356 (64) 38.009 <0.001 30.801 <0.001
L Pu + GP 6696 (671) 7083 (679) 4.187 0.05 5.525 0.02
R Pu + GP 6715 (668) 7083 (691) 3.694 0.06 5.074 0.03
L Pu 4892 (578) 5237 (514) 5.345 0.02 8.105 0.01
R Pu 4897 (530) 5270 (512) 6.665 0.01 9.280 0.01
L GP 1804 (166) 1847 (210) 0.588 0.45 0.180 0.67








F p-value F a
a   After controlling for age at scan and sex
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Sex and age at scan were both retained in the model as the former was weakly (p < 0.1) 
related to structural volumes in all but four regions, and age at scan was related to CC 
volumes.  
CC volumes were about 24% smaller in infected children compared to uninfected 
children. In contrast, nucleus accumbens and putamen were larger bilaterally in infected 
children compared to uninfected children.  Left and right putamen were 7% and 8% larger, 
respectively, in infected children, and left and right nucleus accumbens, 14% and 12% larger, 
respectively.  All volumetric differences remained significant after controlling for the 
potential confounding influences of sex and age at scan.   
Further analysis of the association of structure size with age revealed that, albeit over a 
very narrow age range, age was weakly associated with volume decreases bilaterally in the 
caudate and in the left NA amongst HIV-infected children only, compared to volume 
increases bilaterally in the NA amongst uninfected children (Table 3.5).  The left NA was the 
only structure significantly associated with age in both groups.  Figure 3.1 shows the opposite 
association of age with left NA volume amongst infected and uninfected children.  
Table 3.5  Comparison of the association of age with structure volumes in uninfected and infected 
children. 
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We observe that initially, as well as overall (Table 3.3), HIV-1 infected children had larger left 
NA than uninfected controls.  However, with an increase in age the left NA of HIV-1 infected 
children decreases in size (156mm3 p.a.), whilst that of the uninfected controls increases 
(172mm3 p.a.).   
Figure 3.1 Association of age with left NA volume amongst infected and uninfected children 
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3.4 Effects of Timing of HAART Initiation on Structural 
Volumes 
In Table 3.6 we present a comparison of structural volumes between uninfected children 
and infected children that initiated ART at different times, both before and after controlling 
for potential confounders.   




1 L Caudate+NA 4564 (619) 4678 (415) 4635 (433) 4630 (603) 0.14 0.94 0.102 0.96
2 R Caudate+NA 4772 (583) 4894 (406) 4855 (406) 4846 (566) 0.184 0.91 0.128 0.94
3 L Caudate 4045 (551) 4051 (335) 4099 (385) 4028 (553) 0.059 0.98 0.135 0.94
4 R Caudate 4216 (527) 4252 (348) 4262 (396) 4222 (534) 0.038 0.99 0.062 0.98
5 L NA 520 (124) 627 (140) 536 (101) 601 (126) 2.761 0.05 2.845 0.05
6 R NA 556 (107) 641 (134) 593 (89) 623 (121) 1.824 0.15 2.395 0.08
7 CC 470 (71) 345 (47) 367 (80) 359 (68) 12.7 <0.001 10.37 <0.001
8 L Pu + GP 6696 (671) 7273 (822) 6963 (483) 6965 (645) 2.13 0.11 2.666 0.06
9 R Pu+GP 6715 (668) 7210 (796) 6963 (559) 7047 (698) 1.559 0.21 2.004 0.12
10 L Pu 4892 (578) 5368 (645) 5129 (327) 5181 (486) 2.354 0.08 3.354 0.03
11 R Pu 4897 (530) 5366 (624) 5169 (347) 5255 (514) 2.558 0.06 3.438 0.02
12 L GP 1804 (166) 1905 (222) 1833 (191) 1785 (209) 1.144 0.34 0.979 0.41









ART-96W > Uninfected Controls  p <0.10
L GP
ART-Def > ART-96W p <0.10
Posthocs: Before controlling for confounders
L Pu
ART-Def > Uninfected Controls p <0.05
R Pu
ART-Def > Uninfected Controls  p <0.05
HIV-1 Infected
L NA
ART-Def > Uninfected Controls  p <0.05
ART-96W > Uninfected Controls p <0.10
R NA
L NA
Posthocs: After controlling for Sex and Age
ART-Def > Uninfected Controls p <0.05
R Pu + GP
ART-Def > Uninfected Controls p <0.05
ART-Def > Uninfected Controls p <0.05
ART-96W > Uninfected Controls p <0.10
R NA
ART-Def > Uninfected Controls p <0.05
ART-96W > Uninfected Controls p <0.10
CC
ART-Def, ART-40W,ART-96W < Uninfected Controls p <0.001
L Pu + GP
R Pu
ART-Def, ART-40W,ART-96W > Uninfected Controls  p <0.05
L GP
ART-Def > ART-96W p <0.10
L Pu
ART-Def > Uninfected Controls p <0.01
ART-40W,ART-96W>Uninfected Controls p <0.1
ART-Def, ART-40W,ART-96W < Uninfected Controls p <0.001
L Pu + GP
ART-Def > Uninfected Controls p <0.05
R Pu + GP
ART-Def > Uninfected Controls  p <0.05
ART-Def > Uninfected Controls p <0.05
CC
Values are mean(SD)





(n=18) (n=17) (n=14) (n=13)
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Before controlling for sex and age, only the CC and left NA differed between groups.  
These differences remained significant after controlling for the potential confounding 
influences of sex and age at scan and, in addition, differences in left and right Pu became 
significant.  Post-hoc analyses revealed that in grey matter differences were typically due to 
volumes in the deferred treatment arm being larger than in uninfected children, while CC 
white matter volumes were smaller in children in each of the infected arms compared to 
uninfected control children.  Only in the right Pu were volumes in each of the three treatment 
arms larger than in uninfected controls.  There were no significant volume differences 
between infected children in the three treatment arms.   
Figure 3.2 shows box-and-whisker plots for each structure that revealed a significant 
difference in volume between children in the different groups before controlling for 
potential confounders (left) and the accompanying estimated mean and standard error after 
controlling for confounders (right). 
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Figure 3.2 Box Plots of volumes for different groups in regions exhibiting group differences both before 
(left) and after (right) controlling for the potential confounding influences of sex and age at scan. 
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As there were no significant volume differences between infected children in the three 
treatment arms, the two early treatment arms (ART-40W, ART-96W) were combined for a 
separate analysis of early treatment versus deferred treatment.  Results of this analysis are 
presented in Table 3.7.  
Both before and after controlling for sex and age there were no significant differences 
between deferred and early treatment groups.  As before, ART-Def children had larger 
volumes than uninfected children bilaterally in the NA and Pu.  Further, Pu volumes were 
larger bilaterally also in early treatment children than uninfected children.  CC white matter 
volumes were smaller in both deferred and early treatment children compared to uninfected 
controls.  
Table 3.7 Comparison of Structure size by Treatment Initiation. 
ROI (mm3) F p-value F a p-value
1 L Caudate+NA 4564 (619) 4678 (415) 4632 (511) 4625 (515) 0.213 0.81 0.129 0.88
2 R Caudate+NA 4772 (583) 4894 (406) 4850 (480) 4839 (488) 0.279 0.76 0.164 0.85
3 L Caudate 4045 (551) 4051 (335) 4065 (465) 4055 (454) 0.011 0.99 0.028 0.97
4 R Caudate 4216 (527) 4252 (348) 4243 (458) 4238 (446) 0.032 0.97 0.004 1.00
5 L NA 520 (124) 627 (140) 568 (116) 570 (130) 3.19 0.05 3.512 0.04
6 R NA 556 (107) 641 (134) 608 (105) 602 (117) 2.516 0.09 3.46 0.04
7 CC 470 (71) 345 (47) 363 (73) 389 (84) 19.29 <0.001 15.694 <0.001
8 L Pu + GP 6696 (671) 7273 (822) 6964 (555) 6971 (694) 3.25 0.05 4.003 0.02
9 R Pu+GP 6715 (668) 7210 (796) 7003 (619) 6976 (700) 2.323 0.11 3.058 0.06
10 L Pu 4892 (578) 5368 (645) 5154 (404) 5137 (552) 3.557 0.04 5.114 0.01
11 R Pu 4897 (530) 5366 (624) 5210 (429) 5162 (541) 3.779 0.03 5.228 0.01
12 L GP 1804 (166) 1905 (222) 1810 (198) 1834 (198) 1.527 0.23 1.118 0.33












  ART-Early 
(n=27)






a      After Controlling for Sex + Age at scan
Posthocs: Before controlling for confounders Posthocs: After controlling for Sex and Age
L NA L NA
ART-Def > Uninfected Controls p <0.01
R Pu + GP R Pu + GP
ART-Def > Uninfected Controls p <0.05 ART-Def > Uninfected Controls p <0.01
CC CC
ART-Def, ART-Early < Uninfected Controls p<0.001 ART-Def, ART-Early < Uninfected Controls p<0.001
HIV-1 Infected
 ART-Early>Uninfected Controls p<0.05
 ART-Early>Uninfected Controls p<0.05
R Pu R Pu
ART-Def, ART-Early > Uninfected Controls p<0.05 ART-Def > Uninfected Controls p <0.01
ART-Def > Uninfected Controls  p <0.05 ART-Def > Uninfected Controls p <0.05
L Pu L Pu
ART-Def > Uninfected Controls p <0.05 ART-Def > Uninfected Controls p <0.01
L Pu + GP L Pu + GP
ART-Def > Uninfected Controls p <0.05
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Figure 3.3 shows box-and-whisker plots of the left and right Pu volumes for each group, 
with estimated mean and standard error after controlling for age and sex alongside.   
After controlling for age and sex, when compared to uninfected children, the left and 
right Pu were 12% larger in the deferred treatment group and 7% and 8%, respectively, in 
the early treatment group.   
Figure 3.3  Plots showing differences in Pu volumes between uninfected children and infected 
children receiving either deferred or early treatment both before (left) and after (right) controlling 
for the potential confounding influences of sex and age at scan. 
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3.4.1 Clinical Measures amongst Infected Children 
We examined associations of regional brain volumes with clinical measures amongst 44 
HIV-1 infected children (17 male) comprising 17 ART-Def, 14 ART-40W, and 13 ART-96W.  
Clinical data for these children are summarised in Table 3.8.   
Groups did not differ on most of the clinical variables, except for age of ART initiation 
which was lower in the two early treatment arms than the deferred treatment arm as per 
the study design.  
CD4/CD8 Ratio and CD4% showed no significant differences between groups at 
enrolment, or at time of scanning.  Nadir CD4% also did not differ between groups.  
Plasma Viral load in table 3.8 shows the distribution of children with high, low and 
suppressed viral loads in each of the three treatment arms both at enrolment and at time of 
scanning. A viral load of 400 RNA/ml or higher is considered clinically relevant.  One 
Table 3.8  Sample Characteristics 
 χ2 
F p -value
Median(IQR) 243.0 (25.0) 235.0 (42.0) 257.0 (110.0) 242.0 (40.0) 0.92 0.630
Mean(SD) 34.1 (16.9) 8.7 (1.6) 7.9 (1.6) 18.3 (16.4) 30.67 <0.001
CD4% Mean(SD) 20 (6) 20 (5) 24 (7) 21 (6) 2.03 0.145
CD4% Mean(SD) 36 (9) 36 (8) 36 (8) 36 (8) <0.01 0.998
CD4/CD8 Ratio Mean(SD) 1.37 (0.69) 1.56 (0.94) 1.35 (0.57) 1.43 (0.74) 0.33 0.724
CD4 Count (Cells/mL) Median(IQR) 1889 (840) 1605 (1664) 1836 (1308) 1836 (1225) 0.22 0.895
CD8 Count (Cells/mL) Median(IQR) 1406 (1455) 1293 (953) 1558 (1362) 1398 (1364) 0.86 0.650
High (≥750001) n(%) 11 (69%) 3 (21%) 9 (69%) 23 (53%)
Low (400-750000) n(%) 5 (31%) 11 (79%) 4 (31%) 20 (47%)
Suppressed (≤399) n(%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
CD4% Mean(SD) 40 (8) 34 (7) 38 (9) 38 (9) 1.89 0.165
CD4/CD8 Ratio Mean(SD) 1.57 (0.58) 1.17 (0.52) 1.39 (0.83) 1.38 (0.66) 1.35 0.271
CD4 Count (Cells/mL) Median(IQR) 1284 (608) 1087 (204) 960 (1251) 1125 (472) 2.46 0.292
CD8 Count (Cells/mL) Median(IQR) 978 (554) 1107 (529) 1008 (734) 1010 (563) 0.08 0.962
High (≥750001) n(%) 0 (0%) 0 (0%) 0 (0%) 0 (0%)
Low (400-750000) n(%) 1 (7%) 1 (7%) 2 (15%) 4 (10%)
Suppressed (≤399) n(%) 14 (93%) 13 (93%) 11 (85%) 38 (90%)
8.58 0.014
Plasma Viral Load (RNA/ml)





Values are Mean (SD), Median (IQR), number(%)
χ2 from Kruskal-Wallis ANOVA for non-normal data, F  from Univariate ANOVA for parametric data. 
$  Statistical tests in clinical data were performed for HIV-1 infected individuals only. 
Nadir CD4/CD8 ratio was unavailable
α  1 ART-Def did not have clinical data at Enrolment. (Female)
§  2 ART-Def did not have Clinical Data at Scanning. (1 Male)











Cumulative Treatment [Wks] 
Age at ART initiation [Wks]
0.686
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individual at enrolment and two at scanning did not have PVL data.  At enrolment all cases 
were clinically relevant and none were suppressed.  The proportion of subjects with high and 
low PVLs differed significantly between treatment groups at enrolment due to the fact that 
the ART-40W group had fewer children with high PVL compared to the other two groups.  At 
the time of scanning, most (>85%) of the children in each of the arms had suppressed viral 
loads.   
Table 3.9 presents a comparison of structure size between individuals who had high and 
low plasma viral loads at enrolment.  Volumes in none of the regions differed between 
children with low and high PVLs at enrolment.  This analysis could not be repeated at time of 
scanning as PVL was suppressed in most of the children.   
Mean (SD) Mean (SD) Mean (SD)
L Caudate + NA 4649 (499) 4670 (456) - - 0.02 0.889
R Caudate + NA 4894 (525) 4851 (362) - - 0.10 0.759
L Caudate 4045 (438) 4093 (402) - - 0.14 0.714
R Caudate 4264 (479) 4247 (339) - - 0.02 0.895
L NA 604 (135) 577 (124) - - 0.46 0.499
R NA 630 (131) 604 (98) - - 0.53 0.470
CC 342 (53) 373 (75) - - 2.39 0.130
L Pu + GP 6991 (828) 7176 (477) - - 0.77 0.385
R Pu + GP 7025 (820) 7127 (533) - - 0.22 0.639
L Pu 5167 (631) 5299 (347) - - 0.70 0.408
R Pu 5219 (616) 5303 (366) - - 0.28 0.600
L GP 1824 (233) 1876 (188) - - 0.64 0.428
R GP 1806 (223) 1824 (213) - - 0.07 0.787
p-value
PVL Severity at Enrolment
ROI (mm3)




Table 3.9 Comparison of Structure size by PVL severity at Enrolment 
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Figure 3.4 shows box-and-whisker plots of CD4% at enrolment, prescan and nadir values 
amongst all infected children.  A CD4% of less than 25% is considered immunocompromised, 
and greater than 25% is in the normal range.   
Most children were stable on antiretroviral therapy at the time of scanning (CD4%>25%); 
only 1 child had a CD4% of less than 25%.  At enrolment, 3 children were 
immunocompromised with CD4% less than 25%.   
Nadir CD4% represents the lowest CD4% recorded between enrolment and the date of 
scanning.  As seen in the nadir values, most of the children were immunocompromised at 
some point during the study; for 32 (73%) children CD4% values fell below 25% at some point 
while CD4% for 12 (27%) HIV-1 infected children never dropped below 25%.   
Figure 3.4 Box plot of CD4% at Enrolment, Prescan and Nadir values 
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In Figure 3.5, we present a box-and-whisker plot comparing CD4/CD8 ratios at 
enrolment and prescan amongst the infected children. Reference lines indicate ratios of 1 
(red) and 2 (orange), respectively.  Values below 1 are indicative of HIV-1 infection or 
anaemia, between 1 and 2 is in the normal range for HIV-1 negative individuals or individuals 
stable on ART, values higher than 2 indicate a strong immune system.   
Figure 3.6 Relationship of CD4/CD8 Ratio of each child at Enrolment with their value at Scanning 
Figure 3.5  Box plot of CD4/CD8 Ratio at Enrolment and Prescan 
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Figure 3.6 illustrates how CD4/CD8 ratios changed in each child from enrolment to time 
of scanning. At enrolment,  13 (32%) children had CD4/CD8 ratios below 1, 20 (49%) children 
between 1 and 2, and 8 (20%) children above 2.  At time of scanning, 14 (34%) children had 
CD4/CD8 ratios below 1, 20 (49%) children between 1 and 2, and 7 (17%) children above 2.  
Six children had values below 1 at both enrolment and at  scanning.  Seven children with 
values below 1 at enrolment improved to above 1 at time of scanning, whilst 8 children with 
values above 1 at enrolment decreased to below 1 at time of scanning.   
Further investigation of CD4 and CD8 cell counts separately (Figure 3.7) reveal that, as 
expected, mean CD4 count decreased from enrolment (mean ± s.e = 1996±133 Cells/mL) to 
time of scanning (mean ± s.e = 1307±97 Cells/mL) (t(41) = 5.08, p < 0.001).  Similarly, mean 
CD8 count also dropped from enrolment (mean ± s.e = 1651±138 Cells/mL) to time of 
scanning (mean ± s.e = 1052±74 Cells/mL) (t(41) = 4.20, p < 0.001). The combined effect of 
these changes is that on average CD4/CD8 ratio does not change from enrolment to time of 
scanning.  
Figure 3.7 Comparison of CD4 and CD8 Cell Count at Enrolment and at Prescan 
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In Table 3.10 we present Pearson’s or Spearman Rank Order correlations between 
structural volumes and T-Lymphocyte variables at time of enrolment and time of scanning.   
At enrolment, higher CD8 count was associated with larger left caudal volumes, while 
lower CD4/CD8 ratios at time of scanning were associated with larger caudal volumes 
bilaterally (Figures 3.8 and 3.9). The box plot to the right of the scatter plots in figures 3.8 
and 3.9, which show the mean volume (and 95% confidence interval) for 12 uninfected 
children whose ages fell within the age range of the HIV infected group, suggest that caudal 
volumes in children with low CD4/CD8 ratios at prescan are larger than those of uninfected 
control children.   














L Caudate+NA -0.09 0.559 -0.26 0.093 -0.09 0.586 0.27 0.087
R Caudate+NA -0.11 0.493 -0.26 0.094 -0.11 0.465 0.21 0.192
L Caudate -0.09 0.559 -0.24 0.127 -0.01 0.935 0.31 0.048
R Caudate -0.17 0.276 -0.28 0.069 -0.09 0.586 0.24 0.122
L NA -0.04 0.798 -0.19 0.232 -0.17 0.283 0.09 0.578
R NA 0.19 0.225 -0.01 0.974 -0.14 0.367 -0.14 0.368
CC -0.12 0.462 0.11 0.470 0.24 0.122 0.19 0.233
L Pu + GP 0.03 0.866 -0.11 0.488 -0.11 0.496 -0.05 0.730
R Pu + GP 0.06 0.721 -0.10 0.509 -0.10 0.508 -0.09 0.558
L Pu 0.07 0.675 -0.07 0.653 -0.09 0.570 -0.08 0.596
R Pu 0.05 0.749 -0.08 0.604 -0.15 0.325 -0.09 0.557
L GP -0.07 0.636 -0.18 0.253 -0.08 0.617 0.10 0.510














L Caudate+NA -0.27 0.083 -0.36 0.018 -0.05 0.740 0.14 0.393
R Caudate+NA -0.23 0.148 -0.34 0.026 -0.05 0.737 0.06 0.712
L Caudate -0.30 0.056 -0.40 0.009 0.02 0.882 0.24 0.127
R Caudate -0.24 0.133 -0.38 0.013 -0.11 0.488 0.09 0.551
L NA -0.03 0.847 -0.03 0.848 -0.22 0.157 -0.15 0.340
R NA -0.04 0.824 0.04 0.821 -0.10 0.535 -0.14 0.389
CC -0.04 0.811 -0.09 0.592 0.03 0.827 0.00 0.976
L Pu + GP -0.02 0.895 0.01 0.943 -0.15 0.349 -0.15 0.356
R Pu + GP -0.06 0.694 -0.02 0.877 -0.19 0.219 -0.19 0.220
L Pu -0.01 0.973 0.03 0.867 -0.15 0.350 -0.14 0.391
R Pu -0.05 0.767 0.00 0.995 -0.19 0.217 -0.21 0.188
L GP -0.05 0.743 -0.03 0.872 -0.04 0.818 -0.11 0.488
R GP -0.09 0.586 -0.08 0.628 -0.15 0.350 -0.13 0.399
CD4 Count CD8 Count







Albeit CD4/CD8 ratio only showed weak trends at enrolment, enrolment and prescan 
CD4/CD8 ratios showed stronger and more significant associations with volumes of regions 
of interest than CD4% alone.  CD4/CD8 ratio at prescan explained 8.7% and 8.9% more of the 
variability in the volumes of the left and right caudate, respectively, than CD4%.   
  
  
Figure 3.9 Scatter plot of the relation between right caudate volume and CD4/CD8 ratio at time of 
scanning 




Table 3.11 indicates the association of regional volumes with potential confounders - 
sex and age - as well as how the association with age changes after controlling for sex.  Only 
volumes in right caudate and left and right GP were associated with sex; only bilateral caudal 
and left NA volumes were associated with age.  
Table 3.12 shows how the association of the left and right caudal volumes with CD4/CD8 
ratio at scanning changes when sex and age are included in the model in a stepwise manner.  
Associations of CD4/CD8 ratio at scanning with left and right caudal volumes remained 
significant (β=-0.374, p=0.011 and β=-0.332, p=0.001) after controlling for the potential 
confounding influences of age (left caudate) and both age and sex (right caudate), 
respectively.   
ROI Model = + +
F (p ) R 2 B (p ) β1 (p ) β2 (p ) β3 (p )
L Caudate Model 1 = 7.63 (0.009) 0.16 4420 <0.001 -0.400 (0.009) + - - + - -
Model 2 = 6.20 (0.005) 0.24 7035 <0.001 -0.374 (0.011) + -0.286 (0.048) - -
Model 3 = 4.30 (0.021) 0.18 4611 <0.001 -0.392 (0.010) + -0.143 (0.331)
Model 4 = 4.59 (0.008) 0.27 7312 <0.001 -0.364 (0.013) + -0.293 (0.043) + -0.157 (0.268)
R Caudate Model 1 = 6.75 (0.013) 0.14 4590 <0.001 -0.380 (0.013)
Model 2 b = 5.65 (0.007) 0.27 7790 <0.001 -0.348 (0.016) + -0.352 (0.015)
Model 3 b = 4.85 (0.013) 0.20 4902 <0.001 -0.366 (0.015) + + -0.235 (0.110)






Table 3.12  Stepwise Regression Models for the association of left and right caudal volumes with 
CD4/CD8 ratio at scanning 
Table 3.11 Associations of regional volumes with potential confounders 
Sex
r r β
L Caudate -0.185 -0.330* -0.330*
R Caudate -0.273† -0.399** -0.406**
L NA -0.031 -0.303* -0.303*
R NA 0.075 -0.091 -0.091
CC -0.141 -0.142 -0.142
L Pu -0.242 0.006 0.006
R Pu -0.141 0.016 0.016
L GP -0.276† -0.220 -0.227
R GP -0.283† -0.228 -0.235
ROI Model
Age at Scanning
Values are Pearson r  and beta.  Beta  is normalised regression coefficient 
after controlling for sex, where Sex has association (p <0.10).  
†p <0.10, * p <0.05, **p <0.01
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After Bonferroni correction for possible Type I error that may arise due to the fact that 
associations with CD4/CD8 ratio were repeated in 9 independent structures, none of the 
associations of lower CD4/CD8 ratio with greater regional volumes remained significant (all 
p’s>0.006) 
In Table 3.13 we show the association of regional volumes with age at ART initiation, 
both before and after controlling for sex and age at scan.  The volumes of the left and right 
putamen showed a positive correlation with age at ART initiation (Figure 3.10).   
The box plot to the right of the scatter plot in Figure 3.10 indicates the mean volume 
(and 95% confidence interval) for 12 uninfected controls whose ages fell within the age range 
of the HIV infected group, and suggests that volumes in the putamen region are enlarged in 
infected children with delayed ART compared to uninfected children, in whom volumes are 
typically smaller.  
 








R NA 0.222 0.222
CC -0.015 -0.015
L Pu 0.406** 0.406**





Values are Pearson r  and β  from Linear Regression
Regression Model:
a  -  Regression modelled with Sex
b  -  Regression modelled with Age at scan
c  -  Regression modelled with Age at scan and Sex
Age/Time related variables are only modelled with Sex where applicable.  
      †p <0.10, * p <0.05, **p <0.01
ROI Model
Age at ART 
Initiation
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Figure 3.10  Scatter plots showing association of left and right Pu volumes with Age at ART Initiation 
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3.5 Manual tracing versus Automated FreeSurfer 
Measures 
We compared volumes from manual tracing with those generated using automated 
FreeSurfer tools for both the full sample and for uninfected and infected children separately. 
Data for the uninfected children were analysed separately to assess whether results of 
manual and automated segmentation converge in the absence of possible pathology. 
3.5.1 Bland Altman Analyses 
Table 3.14 presents mean differences and percentage increase/decrease between 
manual and automated volumes.  The volumes of certain structures were either over-
estimated (larger) by automated FreeSurfer whilst others were underestimated (smaller) 
compared to manual tracing measures.  Negative values indicate regions where the mean of 
the automated volume was larger than the manual.   
Due to the large number of comparisons performed (39 tests), the threshold for 
statistical significance was adjusted by dividing 0.05 by 39, generating a critical p-value of 
0.001.  















L Caudate + NA 130 (48) 3% 2.737 0.008 -36 (105) -1% -0.341 0.737 198 (49) 4% 4.063 <0.001
R Caudate +NA 134 (42) 3% 3.223 0.002 -69 (86) -1% -0.803 0.433 217 (41) 4% 5.264 <0.001
L Caudate 285 (42) 7% 6.724 <0.001 205 (95) 5% 2.161 0.045 318 (45) 8% 7.018 <0.001
R Caudate 287 (36) 7% 8.037 <0.001 130 (72) 3% 1.824 0.086 351 (37) 8% 9.407 <0.001
L NA -155 (16) -27% -9.769 <0.001 -241 (30) -46% -8.170 <0.001 -120 (16) -20% -7.391 <0.001
R NA -153 (15) -25% -10.194 <0.001 -200 (28) -36% -7.049 <0.001 -134 (17) -22% -7.845 <0.001
CC -69 (13) -18% -5.174 <0.001 39 (16) 8% 2.507 0.023 -113 (12) -32% -9.017 <0.001
L Pu + GP -599 (63) -9% -9.546 <0.001 -936 (139) -14% -6.742 <0.001 -461 (57) -7% -8.113 <0.001
R Pu + GP -341 (55) -5% -6.235 <0.001 -598 (146) -9% -4.099 0.001 -235 (40) -3% -5.826 <0.001
L Pu -608 (53) -12% -11.571 <0.001 -792 (129) -16% -6.115 <0.001 -533 (49) -10% -10.979 <0.001
R Pu -485 (47) -9% -10.249 <0.001 -711 (127) -15% -5.619 <0.001 -392 (35) -7% -11.341 <0.001
L GP 9 (27) 0% 0.326 0.745 -145 (54) -8% -2.664 0.016 72 (25) 4% 2.816 0.007
R GP 144 (20) 8% 7.037 <0.001 112 (47) 6% 2.395 0.028 157 (22) 9% 7.257 <0.001
Full Sample (n=62) Uninfected Controls (n=18) HIV-1 Infected (n=44)
∆Mean = Mean (Manual Measure - Automated Measure)
s.e. = Standard Error of mean
∆% = Percentage difference from Manual
Adjusted P-Value cut-off p<0.001 
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Notably, automated and manual volumes differed in all regions except the left GP in HIV 
infected children, while there were no significant differences between manual and 
automated measures amongst uninfected children bilaterally in caudate+NA, caudate, GP, 
or CC, suggesting that subtle pathology may contribute to bias between manual and 
automated measures in infected children.  
For example, in uninfected children, automated segmentation yielded marginally 
smaller corpus callosa than manual tracing (differences that were not significant), while in 
HIV-1 infected children automated segmentation resulted in volumes up to 30% larger in this 
region compared to manual tracing.  The larger number of HIV-1 infected children and 
greater difference amongst these children explains the volume increases seen with 
automated segmentation in the full sample in this region. 
As such, differences between automated and manual measures in the left and right 
caudate, CC, and right GP are due to differences amongst infected children only.  
Figures 3.11, 3.12, 3.13 and 3.14 below are Bland Altman Plots showing the distribution 
of the differences between manual and automated volumes as a function of the mean of the 
two measures, for all structures that did not show significant differences in either the 
uninfected children or the overall sample.  The red and yellow lines denote the mean 
differences for the infected and uninfected children, respectively, while the black line 
denotes the mean for the full sample.  A mean near zero indicates the absence of a significant 
difference between manual and automated measures.  Regression analysis of the mean 
difference between measures against the paired mean for each structure revealed no 
proportional bias in areas showing no significant difference. 
Figure 3.11 Bland-Altman Plot of Mean difference between Manual and Automated measures for left 
and right globus pallidus 
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Figure 3.12 Bland Altman Plot of Mean difference between Manual and Automated for left and 
right Caudate +NA 
Figure 3.13  Bland-Altman Plot of Mean difference between Manual and Automated for left and 
right Caudate 
Figure 3.14  Bland-Altman Plot of Mean difference between Manual and Automated for CC 
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Table 3.15, below, is a summary of the correspondence / agreement between volumes 
from manual tracing and automated FreeSurfer segmentation.   
Table 3.15 Comparison of volumes from manual and automated segmentation 
ROI r(X,Y) R² p-value Cronbach's α
L Caudate + NA 0.72 0.516 <0.001 0.84
R Caudate +NA 0.79 0.630 <0.001 0.88
L Caudate 0.75 0.568 <0.001 0.84
R Caudate 0.83 0.693 <0.001 0.90
L NA 0.48 0.227 <0.001 0.64
R NA 0.49 0.244 <0.001 0.64
CC 0.23 0.053 0.071 0.38
L Pu + GP 0.77 0.585 <0.001 0.87
R Pu + GP 0.81 0.653 <0.001 0.89
L Pu 0.76 0.575 <0.001 0.86
R Pu 0.76 0.582 <0.001 0.87
L GP 0.50 0.253 <0.001 0.67
R GP 0.62 0.389 <0.001 0.81
ROI r(X,Y) R² p-value Cronbach's α
L Caudate + NA 0.71 0.503 0.001 0.82
R Caudate +NA 0.80 0.646 <0.001 0.89
L Caudate 0.69 0.483 0.001 0.81
R Caudate 0.83 0.697 <0.001 0.91
L NA 0.44 0.194 0.067 0.61
R NA 0.43 0.186 0.074 0.60
CC 0.54 0.292 0.021 0.70
L Pu + GP 0.76 0.582 <0.001 0.84
R Pu + GP 0.73 0.531 0.001 0.82
L Pu 0.70 0.484 0.001 0.80
R Pu 0.68 0.469 0.002 0.79
L GP 0.47 0.218 0.050 0.60
R GP 0.48 0.233 0.043 0.64
ROI r(X,Y) R² p-value Cronbach's α
L Caudate + NA 0.76 0.576 <0.001 0.86
R Caudate +NA 0.84 0.701 <0.001 0.91
L Caudate 0.79 0.629 <0.001 0.86
R Caudate 0.86 0.743 <0.001 0.91
L NA 0.60 0.357 <0.001 0.75
R NA 0.54 0.288 <0.001 0.68
CC 0.45 0.204 0.002 0.60
L Pu + GP 0.84 0.712 <0.001 0.92
R Pu + GP 0.93 0.856 <0.001 0.96
L Pu 0.81 0.663 <0.001 0.90
R Pu 0.86 0.738 <0.001 0.94
L GP 0.67 0.444 <0.001 0.65




Adjusted P-Value cut-off p<0.001 
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The strongest correlation observed between automated and manual segmentation was 
in the right lentiform nucleus of HIV-1 infected children, where 85.6% of the variability seen 
in manual segmentation was explained in the automated segmentation (Cronbach’s α=0.96).  
The weakest correlation observed between automated and manual segmentation was in the 
corpus callosum for the whole sample where only 5.3% of the variability seen in manual 
segmentation was explained in the automated segmentation (Cronbach’s α=0.38).   
Overall, there were stronger correlations for grey matter structures amongst HIV-1 
infected children (Cronbach’s α=[0.60-0.96], R2=[0.288-0.856]) as compared to the full 
sample (Cronbach’s α=[0.64-0.90], R2=[0.227-0.693]) and uninfected controls (Cronbach’s 
α=[0.60-0.91], R2=[0.186-0.697]).  In uninfected controls associations between manual and 
automated volumes were not significant (after correction for multiple comparisons) in the 
left and right nucleus accumbens, left and right GP, and right putamen. 
The corpus callosum had a stronger correlation with manual segmentation amongst the 
uninfected children (Cronbach’s α=0.70, R2=0.292) compared to HIV-1 infected children 
(Cronbach’s α=0.60, R2=0.204), however was not significant after correction for multiple 
comparisons in any of the 3 groups.  Figure 3.15 is a scatter plot of manual against automated 
CC volumes, with reference line of perfect correlation (black).  The red and yellow lines 
denote the relation in HIV-1 infected and uninfected controls, respectively. In infected 
children automated volumes are typically larger than manual volumes, while they are smaller 
than manual volumes amongst the uninfected children.  
Figure 3.15 Scatter Plot of Manual versus Automated for CC 
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3.5.2 Group Differences using Automated FreeSurfer Measures 
A central question to this thesis was whether regions where we observe volumetric 
differences between diagnostic groups would change if we use volumes obtained using 
automated measures compared to those obtained using manual tracing.  Using volumes 
obtained from FreeSurfer, we found no significant differences between diagnostic groups, 
except for the left globus pallidus where HIV-1 infected children were found to have a 
significantly smaller left globus pallidus (mean±s.e.=1775±29mm3) than uninfected controls 
(mean±s.e.=1949±60mm3) (F(1, 61) = 8.60, p = 0.005).  In contrast, it was shown previously 
(Table 3.3) that manual tracing revealed 5 different structures (bilateral NA, bilateral Pu, and 
CC) with significant differences in volume between infected and uninfected children.
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CHAPTER 4 DISCUSSION 
This discussion will focus on two main sets of findings, the effects of HIV and HAART on 
structure size and the congruence between manual and automated segmentation.  This 
discussion will suggest possible explanations for the results that were obtained, as well as 
future avenues for research.  This data could advance our understanding of the clinical and 
cognitive manifestations of HIV-1 in infected children, as well as elucidate upon 
segmentation measures that most accurately describe the neuroanatomy and pathology in 
children.   
4.1 Effects of HIV-1 Infection and HAART on Regional brain 
volumes 
In contrast to previous studies in HIV-infected adults that observed global atrophy 
(Becker et al. 2011; Chang et al. 2011; George et al. 2009; Sarma et al. 2014), the findings of 
this study suggest that pre- or postnatal HIV-1 infection and HAART result in localised 
subcortical volume increases in the brains of Xhosa children at or around 5 years of age, 
specifically in the nucleus accumbens (NA) and the putamen (Pu), effects that remained 
significant after controlling for the potential confounding influences of age and sex.  
Although there were no volumetric differences between children in the three different 
treatment arms, children in the ART-Def group showed the largest volume increases 
compared to uninfected control children.  This result is consistent with the finding that 
increasing age at ART initiation was associated with greater volumes bilaterally in the Pu.  In 
contrast, the corpus callosum (CC), which is the primary white matter structure responsible 
for inter-hemispheric connections, was reduced to the same extent in HIV-1 infected children 
from all three treatment arms compared to uninfected controls.   
Notably, albeit over a small age range, increasing age was associated with volume 
decreases in the caudate and left NA amongst infected children, but with volume increases 
in the NA amongst the uninfected children.  This volume decrease with increasing age 
amongst infected children could explain the atrophy associated with HIV in adults, although 
the reason for the observed volume increase in early childhood is unclear. 
Amongst infected children, the mean CD4 and CD8 T-cell counts both decreased as 
expected with age from enrolment to scanning.  Children have naturally high CD4 and CD8 
T-cell counts, which decrease with age and thus differ greatly from that of adults (Paul et al.
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2005; Shearer et al. 2007).  The CD4/CD8 ratio remained constant from enrolment to scan 
date and within the normal range.  We observed that CD4/CD8 ratio showed stronger 
associations with structure volumes than CD4%.  Unexpectedly, amongst infected children, 
poorer immune health at the time of scanning, as evidenced by lower CD4/CD8 ratio, was 
associated with greater caudal volumes, effects that did not survive Bonferroni correction 
for multiple comparisons.  
Thus, in three of four subcortical grey matter regions examined, we observe volume 
increases at age 5 years in infected children (effects that are strongest in children who 
initiated ART later in life) or children with poorer overall health, as evidenced by lower 
CD4/CD8 ratios.  The globus pallidus (GP) is the only region where we did not observe volume 
increases associated with HIV infection. 
The absence of volume reductions in our study may be due to current inflammation, 
reactive gliosis, apoptotic inhibition, and leukocyte infiltration in the areas of interest causing 
them to be abnormally larger (Ernst, Chang & Arnold 2003; George et al. 2009; Reid et al. 
2001).   
Reactive gliosis is described as the non-neoplastic proliferation of glia, most commonly 
astrocytes and occasionally microglia, in response to injury.  This may exacerbate HIV 
infection in the brain as it has been shown that HIV preferentially targets astrocytes and 
microglia (Blumberg, Gelbard & Epstein 1994; Mitchell, Wendy 2001; van Rie et al. 2007; 
Tornatore et al. 1994).  Astrocytes have functional HIV co-receptors (CCR5 and CXCR4) that 
could facilitate infection (Klein et al. 1999).  Even in the absence of current acute 
inflammation and transient virologic increases, the engagement of these receptors by 
chemokine ligands (CCL3 and CCL5) that are increased in the brains of HIV-infected 
individuals, could alter astrocyte function and increase BBB permeability (Ivey, MacLean & 
Lackner 2009; Klein et al. 1999).  Furthermore, once infected the release of CCL2 by 
astrocytes as a possible neuroprotective mechanism inhibits apoptosis in astrocytes and 
neurons against the toxic effects of Tat (from HIV) or glutamate (Ivey, MacLean & Lackner 
2009).  The lack of apoptosis and recruitment and activation of phagocytic cells could further 
exacerbate the inflammation and cause relative increases to structure size.  This may explain 
why observed volume increases in our study were typically largest in children in the ART-Def 
arm who initiated ART only when they presented with certain clinical criteria, as one would 
expect effects of reactive gliosis and apoptotic inhibition to be more severe in these children 
in whom viral load was suppressed only later in life compared to children who initiated ART 
early (before 12 weeks of age).   
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The highest concentration of HIV is found in the caudate nuclei and CC (Ances et al. 2012; 
Thompson et al. 2006), possibly due to their close association with the ventricles, which may 
explain the association seen in the caudate with CD4/CD8 ratio as a measure of immune 
health.  The proximity of these structures to the ventricles, and in turn the CSF, allows for 
easier penetration of HIV-infected mononuclear cells permitting higher concentrations of 
HIV toxins in these sites (Ances et al. 2012; Andronikou et al. 2014; McClernon et al. 2001; 
Oster et al. 1993; Thompson et al. 2006).  This would in turn also apply to ARVs which more 
readily permeate through the BBB.  The fact that the uninfected children who showed age-
related volume increases in certain structures are marginally older and span a larger age 
range than the infected children who, in contrast, show age-related volume decreases, may 
conceal some subtle group differences.  Controlling for sex and age at scan did not, however, 
alter the results of the group comparison.   
Grey matter has larger numbers of glial cells, such as protoplasmic astrocytes to support 
the neuron’s metabolic demands, than white matter, and comparatively larger microglia in 
the presence of pathology.  The preferential targeting of astrocytes and microglia by HIV 
would thus naturally precipitate reactive gliosis and neuronal cell loss in these areas 
(Blumberg, Gelbard & Epstein 1994; Ernst, Chang & Arnold 2003; Hahn et al. 2013; Tornatore 
et al. 1994).  Microglia are phagocytic antigen presenting cells that are mobilized after CNS 
injury or infection (Kandel, Schwartz & Jessell 2000).  Since microglia are macrophage 
derived, they carry the presence of CD4 receptors making them vulnerable to HIV attack 
(Kandel, Schwartz & Jessell 2000).  During inactivation/resting state these cells are relatively 
small and have undulating processes with spine-like projections.  The function of microglia 
during resting state is unknown (Kandel, Schwartz & Jessell 2000). However, once activated 
and recruited upon the onset of infection or injury, the cells’ processes become more 
protuberant and furcated than that of inactivated cells, making them difficult to distinguish 
from recruited phagocytes and perivascular cells.  Microglia are thought to become activated 
in a number of diseases including multiple sclerosis and AIDS-related dementia, as well as 
more chronic neurodegenerative diseases, like Alzheimer’s (Kandel, Schwartz & Jessell 
2000).  
These protoplasmic astrocytes and microglia cells are not as abundant in white matter.  
The CC, which contains mostly neuronal axon fibres with oligodendrocytes and myelin and 
fewer neuronal cell bodies than grey matter, requires fewer protoplasmic astrocytes due to 
decreased metabolic demands and are substituted with fibrous astrocytes.  The effects of 
inflammation in white matter would thus not be as prevalent as in grey matter.  Evidence of 
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cell loss in the CC has, however, been observed via MRS and immunohistochemically stained 
animal model studies (Chang et al. 2002; Hahn et al. 2013).  Rat models have shown reduced 
oligodendrocyte populations and equivalent microglial increases in the presence of HIV 
within the CNS (Hahn et al. 2013).  The loss of these support cells may result in perturbations 
to neuronal pathway function as well as facilitate further neuronal cell loss.  Neuronal cell 
loss in affected grey matter would naturally cause repercussive thinning of the CC as axonal 
fibre tracts project via the CC from their cell bodies located in affected grey matter areas 
(DeLong 2000).  This additive loss of neuronal axon tracts and accompanying 
oligodendrocytes may have an additive effect resulting in the smaller CC size we observe in 
HIV infected children.  Therefore, decrease in structure size due to the summated loss of 
support cells and neuron tracts may greatly outweigh subtle hypertrophy, via proliferation 
and recruitment of phagocytic cells, such as microglia and fibrous astrocytes.   
It has been shown that one defining pathological feature of HIV encephalopathy is 
diffuse white matter involvement that becomes more pronounced in the advanced stages of 
the disease (Pomara et al. 2001). In our study, the most significant difference between 
infected and uninfected individuals was observed within the CC.  The CC of HIV infected 
children was found to be on average 24% smaller at age 5 years than in their uninfected 
counterparts.  Numerous researchers have observed similar HIV-associated size reductions 
within the CC (Chiang et al. 2007; Dewey et al. 2010; Hasan et al. 2009).  Thompson et 
al.(2006) reported a 25% decrease in the thickness of the CC in HIV infected adults compared 
to uninfected controls – an effect that was most prevalent within the anterior portions of 
the CC (Thompson et al. 2006).  They also observed that the overall thickness of the CC is 
affected by loss of peripheral white matter, making this finding important for clinical settings. 
As, CC thickness, and volume may be used as a biomarker to test overall global white matter 
integrity (Andronikou et al. 2014; Thompson et al. 2006).  Andronikou and colleagues 
examined CC volume and thickness as a biomarker of global white matter integrity in 33 
South African children (age 7 – 49 months) diagnosed with HIV-related brain disease, all 
receiving ART.  Since all children received MRI due to clinical indications, the study lacked 
uninfected controls (Andronikou et al. 2014).  They observed that linear measurement and 
thickness of the motor segment of the CC associated with the degree of mental 
development.  Although we did not analyse specific areas of the CC, this finding ties in with 
the subcortical grey matter areas (containing motor function domains) found to be affected 
in our study, as well as impairments to locomotor function described in our cohort (Laughton 
et al. 2012).  Note should be taken that both African and mixed race individuals from low 
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socioeconomic background were included in Andronikou’s (2014) study.  In the present 
study, mixed race children (Cape Coloured) were excluded as volumes of subcortical 
structures significantly differed between Xhosa and Cape Coloured uninfected controls 
(Appendix A).   
As the Pu and NA are located marginally further away from the ventricles than the 
caudate, these structures are perhaps not as readily penetrated by the HIV-infected 
mononuclear cells.  However, once HIV invades the area and viral infection spreads, removal 
of metabolic waste and virions may be slower compared to that of the caudate.  This may 
explain the larger Pu and NA observed in HIV infected children.  Thus presence of 
inflammation in the form of reactive gliosis and leukocyte infiltration, resulting in slightly 
increased structure size, may be because of prolonged HIV exposure in the Pu and NA rather 
than present acute transient viral increases, as per the caudate.   
The clinical manifestations of HIV-1 infection in these children do not paint a clear 
picture of causation.  Plasma viral load (PVL) was suppressed (≤ 399 RNA/ml) in 90% of 
children at time of scanning.  A previous study in 128 perinatally infected children found that 
21% showed characteristic evidence of HIV infection induced encephalopathy, despite at 
least 74% of these children having viral load suppression at the time of diagnosis (Cooper et 
al. 1998).  Findings of viral load suppression in the systemic blood supply may, however, not 
be representative of the compartmentalised and unique viral reservoirs in the CNS (Pillai et 
al. 2006; Strain et al. 2005).  
Further, there could be ongoing effects from damage or delayed development arising 
during the initial phases of HIV invasion, prior to HAART initiation.  In our study, all HIV 
infected treatment groups were clinically relevant with PVL ≥ 400 RNA/ml at enrolment.  The 
PVL of the deferred group resembled that of the ART-96W group, where most children (69%) 
had PVL above 750000 RNA/ml, whilst PVLs were between 400 and 750000 RNA/ml in 79% 
of children in the ART-40W group.  These differences in PVL at enrolment may explain why 
the L NA is less enlarged in the ART-40W group compared to uninfected children than in the 
ART-96W group, since viral penetration into the CNS occurs early on in infection (Ivey, 
MacLean & Lackner 2009).  Neuroinvasion by HIV can occur as early as the initial 10 days 
post-infection (Lackner et al. 1994).  The primary mode of neuroinvasion involves monocytes 
infected with HIV entering the brain during routine immune surveillance and replacement of 
perivascular macrophages (Annunziata 2003).  Significant differences have been observed 
previously in a sample of vertically infected children between 6 months to 18 years of age, 
where disturbances to CNS were associated with VL within the CSF, whilst no associations 
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were found with PVL (Sei et al. 1996). Importantly though, those findings were reported 
cross-sectionally after the initial infection and viral insult from 6 months post-
seroconversion.  Thus observations in our study of fewer and less severe differences in 
structure size in the ART-40W group compared to the ART-96W group, which had more 
individuals with low PVL at enrolment, may indicate that even early HAART administered at 
around 8.3 ± 1.6 weeks of age is perhaps too late for individuals already experiencing high 
viral loads.  Damage to the basal ganglia, and thus corpus striatum is dictated by the rate of 
initial insult (Becker et al. 2011).  These findings suggest that early therapy before severe 
viral replication would be advantageous.  The association of increased structure size of the 
left and right putamen with increased delay to initiate ART provides further evidence of the 
benefit of early ART.  Unexpectedly though, we did not find any differences in regional 
volumes at age 5 years between children who had high or low PVLs at enrolment. A 
confounding issue here may be the duration of HAART itself, where one group received 
HAART for 40 weeks and the other for 96 weeks before interruption.  It is possible that ART 
interruption negates some of the benefits of early ART. It has also been shown that HAART 
decreases motor and working memory performance in both children and adults (Chang et al. 
2008; von Giesen et al. 2003), which suggests that there may be some complicated interplay 
between the benefits and risks associated with early ART.   
Since associations between clinical variables and volumes differ in different brain 
regions, it appears that different structures are impacted in a unique way by HIV and/or ART, 
albeit bilaterally. The basal ganglia plays an integral role in motivation and learning, and 
movement related functions (DeLong 2000).  Although the putamen is interconnected with 
many structures and as such is involved in many integrated functions, its two main functions 
are motor and learning (DeLong 2000; Packard & Knowlton 2002).  It has also been 
hypothesized that the putamen plays a role in the selection of movement and the 
performance of previously learned movements (Griffiths, Perry & Crossman 1994).  As such, 
damage to this area would present as deficits in motor function and learning.  Deficits in 
motor function, presenting as spastic diplegia, have been reported amongst HIV-infected 
children in South Africa (Langerak et al. 2014).  Other researchers have also noted these 
functional impairments in gross motor skill and function - mainly when comparing HIV-
infected with uninfected children (Abubakar et al. 2008; Epstein et al. 1986; van Rie, Mupuala 
& Dow 2008). Perturbations in locomotor function have also been observed in children from 
our cohort via the Griffiths Mental Development Scales, albeit at an earlier age (10-16 
months) (Laughton et al. 2009).   
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4.2 Automated versus Manual Segmentation 
To our knowledge, this is the first study to manually segment structures of the basal 
ganglia in such a large cohort of children, especially in children with possible pathology linked 
to HIV infection with ART initiation at different times in infancy.  Most studies investigating 
the reliability of manual versus automated segmentation have mainly assessed the 
hippocampus, with very few investigating individual structures of the basal ganglia (Barnes 
et al. 2008; Boccardi et al. 2011; Hsu et al. 2002; Morey et al. 2009; Mulder et al. 2014; 
Sánchez-Benavides et al. 2010; Shen et al. 2010; Tae et al. 2008).   
Amongst uninfected children, we found that FreeSurfer overestimated both the left and 
right NA by 46% and 36%, respectively.  Similarly, the left and right Pu were overestimated 
by 16% and 15%, respectively.  No differences were found in the caudates, CC or GP.  This 
suggests that similar overestimations may be expected in normal non-pathological Xhosa 
children around a similar age.   
Amongst the HIV infected children, automated and manual volumes differed in all 
regions examined (all p’s<0.001), except the left GP (p=0.007) where the difference did not 
survive Bonferroni correction for multiple comparisons.  The largest difference between 
automated and manual measures was in the CC where automated volumes were 32% larger.  
The CC, bilateral NA and Pu were overestimated, whilst the bilateral caudates and right GP 
were underestimated.  
Notably, the NA and Pu volumes from automated measures were larger than those 
obtained using manual tracing amongst both infected and uninfected children, and in the 
sample as a whole.  These are also the areas that were larger in infected children compared 
to uninfected children via manual segmentation.  It is possible that the overestimation of 
volumes using automated segmentation in these areas is due to different conventions for 
selecting boundaries, introducing bias into the measures.  The fact that manual and 
automated measures were correlated in these areas amongst both infected and uninfected 
children (albeit more strongly so amongst infected children), suggests that different 
conventions may be the source of the discrepancy and that group differences arising from 
pathology may be preserved despite these differences.  Unfortunately, group comparisons 
using volumes obtained from automated segmentation showed no differences in the NA and 
Pu, suggesting that differences arising from subtle pathology may be lost during automated 
segmentation.   
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Morey et al. in their study  in 20 adults comparing manual tracing with FreeSurfer and 
FIRST, observed overestimation of volumes obtained using the two automated methods 
compared to manual tracing in both hippocampal and amygdala regions (Morey et al. 2009).  
This is consistent with our findings in uninfected children, where all the significant 
differences were due to overestimation of volumes by FreeSurfer, albeit in different brain 
regions.   
Dewey and colleagues conducted a study involving 120 HIV infected patients, mean age 
47.3±7.2 years (Dewey et al. 2010).  Although they did not strictly use manual segmentation, 
except for reliability testing of a subset, they did test various automated segmentation 
packages against one another and with auto-assisted manual segmentation (AAM).  They 
observed that FreeSurfer exhibited statistical differences in 3 of the 8 areas examined, with 
all structures being overestimated by FreeSurfer.  Unfortunately, the only regions 
investigated that were in common with ours were the caudate and putamen. They reported 
mean differences in the left caudate and left putamen of 6.76% and 13.99%, respectively 
(Dewey et al. 2010). Although the overestimation of the Pu volumes by FreeSurfer amongst 
infected children in our study were similar, caudal volumes by FreeSurfer were smaller by 
roughly 8% in our study. 
4.2.1 Association of Structure Size Between Segmentation Techniques 
Following correction for multiple comparisons the automated measurements of the CC 
had no association with manual segmentation in any of the groups.  Amongst the uninfected 
children, the Cronbach’s alpha Intraclass Correlation Coefficient (ICC) in the CC was 0.70, 
whilst only 29% of the variability in the data from manual segmentation could be described 
by the automated volumes of this structure.  Similarly, in the infected group with a 
Cronbach’s alpha of 0.60 in the CC, only 20% of the variability in the manual data could be 
explained by the automated measures.   
After Bonferroni correction for multiple comparisons, the uninfected group’s automated 
measures showed no association with manual measures bilaterally in the NA, GP and right 
Pu. Except for the GP, differences between manual and automated measures were 
significant in these regions. Caudal manual and automated volumes were correlated and did 
not differ significantly.  
In contrast, amongst infected children, despite the fact that automated volumes were 
correlated with manual volumes in all grey matter ROIs, all the regions (except the left GP) 
showed significant differences between manual and automated volumes. Also, NA and Pu 
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volumes were typically larger by automated segmentation, while caudal and GP volumes 
were smaller. These results demonstrate that automated segmentation may not be able to 
accurately segment regions in the presence of subtle pathology.  The enlarged subcortical 
grey matter regions observed in the brains of the HIV infected children, resulting possibly in 
more vivid definition of structure outlines, as well as mimicking better an adult brain, for 
which the aseg+aparc 2009 training atlas was derived, may account for the high number of 
associations between automated and manual segmentation within the HIV-1 infected group.  
Fischl et al. (2002) assessed the reliability of their automated segmentation methods.  
The overall outcome of their study was convincing.  However, their training atlas was 
generated using only 12 manually labelled datasets (the age range is not mentioned in the 
paper) (Fischl et al. 2002).  The study assessing the reliability of this atlas mentions study 
participants with normal cognition (controls) and subjects with increasing cognitive decline 
in the presence of Alzheimer’s Disease (Fischl et al. 2002).  These study participants ranged 
upwards of 67 years of age and resulted in extremely favourable association between their 
automated and manually segmented measures.   
The relatively inflated Cronbach’s alpha coefficients are a problematic outcome.  While 
some studies assess the congruence between various segmentation measures using multiple 
statistical analyses (Bendersky et al. 2006; Dewey et al. 2010; Morey et al. 2009), many use 
Cronbach’s alpha to gauge the agreement between manual segmentation of a subset of the 
data and automated segmentation protocols (Dewey et al. 2010; Knickmeyer et al. 2008; 
Shen et al. 2010; Tae et al. 2008).  Cronbach’s alpha is not sensitive enough to be used as a 
standalone measure for gauging reliability.  Observation of the Pearson’s coefficient of 
determination between automated and manual measures revealed consistently low 
association between measures as compared to Cronbach’s alpha.  This is expected as 
Pearson correlation is a more sensitive statistical test.   
Since our results demonstrated differences between volumes obtained using automated 
segmentation and those obtained using manual tracing, and since these differences differed 
between infected and uninfected children, we were interested in assessing whether group 
differences obtained using manual tracing would be preserved using automated measures.  
Using automated measures only one group difference was found – a smaller left GP in 
infected children compared to uninfected controls.  In contrast, manual segmentation 
revealed group differences in 4 grey matter regions (bilateral NA and bilateral Pu), all of 
which were larger in infected children compared to uninfected children, as well as a smaller 
CC in infected children.   
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4.2.2 Disagreement of Automated Structure Delineation 
The exact boundaries of the NA on MR images are a contentious issue, even between 
expert manual tracers, since this structure can only truly be delineated from surrounding 
structures cytoarchitectonically (Makris et al. 2004; Neuromorphometrics Inc. 2007).  The 
manual tracer draws upon knowledge of surrounding tissues and structures in delineating 
the structure of interest.  Although manual tracing is inherently subjective, the tracer relies 
upon intuition and subjectivity to elicit more reliable segmentation of subcortical areas of 
interest.  Since FreeSurfer segmentation relies upon voxel intensity and contrast to delineate 
structures, the naturally low contrast between white matter and arteries, pose a problem 
that is known to affect segmentation accuracy.   
Three-dimensional image acquisition, such as 3D MEMPRAGE sequences, require 
repetition of all phase encoding steps in the slab direction.  The inversion pulse is thus placed 
before the partition encoding loop (Runge, Nitz & Schmeets 2009).  Within the partition 
encoding loop, the recovery of the longitudinal magnetisation causes the signal change.  T1 
weighted imaging benefits from the 3D MEMPRAGE sequences.  The partition encoding loops 
used in 3D acquisitions allow for continuous coverage with thin slices in a reasonable 
measure of time, unlike that of multi-slice 2D imaging (Runge, Nitz & Schmeets 2009).  The 
use of inversion pulse allows for better control over T1-weighting, allowing higher levels of 
contrast, compared to spin echo and 2D gradient echo imaging (van der Kouwe et al. 2008; 
Runge, Nitz & Schmeets 2009).  The first pitfall with the 3D MEMPRAGE is the flow sensitivity 
of this sequence and is based on time-of-flight effects.  This occurs when the blood flowing 
into the imaged volume causes changes to the amplitude of the signal.  The second is phase 
effects, where, during applied gradients, there is a phase change due to the motion of the 
blood (Kim & Parker 2012).  Therefore, the playoff of increased contrast between grey and 
white matter, using MEMPRAGE sequences in our sample, has had the effect of decreasing 
the amount of contrast between white matter and arterial supply.  Voxels arising from closely 
associated arteries with white matter would thus appear with similar signal intensity and 
would introduce bias to the automated segmentation results, especially in the case of the CC 
and anterior cerebral artery.   
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Figure 4.2 shows a sagittal slice from an MR image of an HIV-1 infected child in our study.  
The light purple area is the CC.  The image has been segmented using FreeSurfer and shows 
to what extent automated segmentation would overestimate the CC as a result of this lack 
of contrast between the arteries and the white matter (above the red dashed line).  The red 
dashed line indicates where the manual tracer does not agree with the automated 
delineation of the CC, as arterial branches off of the anterior cerebral artery are clearly visible 
(indicated with green arrows).   
 
Figure 4.1  Sagittal view of corpus callosum (CC) with areas of disagreement between manual and 
automated measures indicated. The red dashed line indicates the boundary drawn by the manual 
tracer. The green arrows indicate arterial branches of the cerebral artery.  
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Figure 4.3 illustrates a coronal view from the same MR image.  The areas of the basal 
ganglia have been labelled, and areas of disagreement are indicated by arrows A to D.   
Label A indicates areas where grey matter projections between the caudate and 
putamen have been labelled as white matter by FreeSurfer (in green and white).  The 
discolouration of voxels can be seen projecting between the two structures.   
Labels B and C indicate a discoloured band toward the inferior border of the putamen 
(B) and nucleus accumbens (C).  This area consists of white matter.  It extends downward
from the septum pellucidum and forms the inferior border of both the putamen and NA, and 
separates them from the straight gyrus, anterior olfactory cortex, and olfactory tubercle.   
Label D indicates the incongruence in the delineation of the border between the NA and 
caudate.  This delineation can only truly be made cytoarchitectonically, it is generally 
accepted amongst neuroanatomists that a straight line from the inferior most point of the 
ventricle to the inferior most border of the internal capsule is sufficient in separating these 
two structures (Makris et al. 2004; Neuromorphometrics Inc. 2007).  This instance of 
disagreement is merely protocol related which may differ between measures.  As even within 
Figure 4.2 Coronal view of FreeSurfer delineation with areas of disagreement indicated with 
arrows A to D. (Caud = caudate, Pu = putamen, NA = nucleus accumbens)
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manual tracing between tracers, specific delineation may differ depending on the protocol 
used within the training datasets.   
It is important to note that much of the existent literature comparing automated and 
manual tracing has been compiled by researchers from various disciplines such as 
neuroscience, physics, and biomedical engineering.  However, these studies are often field 
specific.  Given the various fields, abilities in understanding and specialized knowledge would 
naturally differ between disciplines.  However, the organic nature of the brain renders it 
subject to human variation that is unique to the individual.  This makes the knowledge of a 
neuroanatomist a valuable addition to this field of research.  Thus, a multidisciplinary 
approach, incorporating the specialist knowledge of such disciplines as anatomy, biomedical 
engineering, neurophysiology, and physics would enrich the nature of the literature 
surrounding this topic and aid assimilation of knowledge of the dynamic, organic nature of 
the brain in addition to reliable and valid ways to measure such an organ reproducibly.  It is 
for this reason that the AAM method for delineating structures of interest, posed by Dewey 
et al. is perhaps the most parsimonious approach.  The AAM method allows for the relative 
decreases to cost and time whilst still maintaining and incorporating the specialized 
knowledge-guided alterations to computer generated segmentations of a 
neurobiologist/neuroanatomist.   
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4.3  Limitations 
Detailed statistical analyses were only performed on volumes in native space.  The 
structures were not standardised for intracranial volume (ICV).  However, as the group 
contained only children originating from a Xhosa ancestry, biological variation was assumed 
to be fairly low.  Data from automated measures were also derived in native space, without 
standardising for ICV.  Both male and female children were included in this study, however 
possible confounding influences of sex were investigated and controlled.  Age at time of 
scanning proved to be more important than originally anticipated, considering that all 
children were between 5 and 6 years old at the time of scanning.  Since children in this age 
range may be undergoing dynamic developmental changes, and children in the uninfected 
group were marginally older than HIV-1 infected children, it was important to control for age.  
Furthermore, HIV-1 infected children had been infected since birth, so that their period of 
infection corresponded with their age.  
Due to the sheer number of structures as well as the large number of independent 
variables considered within this study, it was necessary to control for multiple comparisons.  
Use of Bonferroni and False discovery rate (FDR), in the form of Benjamini-Hochberg FDR 
analyses, were investigated as possible solutions to this problem.  It was chosen to err on the 
side of caution and apply the more conservative Bonferroni correction.   
Both Bonferroni correction and Benjamini-Hochberg FDR apply the assumption that 
individual tests, and thus independent variables, are mutually exclusive from one another 
(McDonald 2014).  In our dataset this is not the case.  Age and sex are naturally associated 
with body size, even in children.  Our clinical independent variables PVL, CD4%, CD4/CD8 
ratio, CD4 count and CD8 count are also not mutually exclusive variables as they all 
somewhat describe the relative state of current infection.  Similarly, it would be amiss if our 
dependent variables of structure size were completely independent of each other, at least 
in terms of the size with surrounding structures within each child’s basal ganglia, as they 
share boundaries and ICV.  Using Bonferroni it was thus necessary to define the “family” of 
statistical tests for which the corrections would be applied.  We chose this as being the total 
number of permutations being investigated within a defined statistical test, disregarding the 
lack of mutual exclusivity between variables in neighbouring analyses.  This was to further 
our stance in erring on the side of caution in attempting to lessen the degree of Type-I error.  
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Correlating CD4 count, CD8 count and plasma viral load with structural volume data may 
not be beneficial because of HIV-1 having unique cell preferences in the brain (macrophage, 
microglia, astrocytes etc.).  Thus, studying these relationships of constituents in blood tests 
may not be a true representation of HIV and HAART’s effects on the brain.  Genetic 
differences in the compartmentalised populations of HIV within the CSF and brain differ 
remarkably from what is observed in the blood.  
Guardians/parents with HIV infected children who participated in this study were 
committed to helping their children.  These parents/guardians may have inadvertently given 
extra care, attention and nurturing to their children and perhaps aided in their 
neurocognitive development possibly skewing some results (Mellins et al. 2003).  These 
children may also have received improved care compared to infected children receiving 
standard community care. 
Adherence to treatment regimen both during pregnancy and throughout the trial was 
undefined.  Intasan et al.’s comparison of adherence strategies showed self-reporting had a 
stronger association with virologic failure than VL monitoring  (Intasan et al. 2014).   
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4.4 Future Studies 
Use of an active rat/ humanised mouse model to simulate perinatal HIV infection and 
development of the CNS is needed.  Firstly, to monitor the reactive gliosis and characteristics 
of inflammation in the brain.  Secondly, to immunohistochemically track changes in cell types 
in white and grey matter separately.  Thirdly, to monitor the unique viral populations and 
immunorecruitment within the CNS.  This will aid in elucidating whether the increase in 
structure size observed in this study is as a result of inflammation unique in children 
compared to adults.   
Assimilation of the findings of this study with concurrent studies involving the same 
cohort of children would be advantageous.  This would include associating structure size with 
the neurological tests conducted at the time of scanning.  This will provide insight into 
structural-functional relationships involving the basal ganglia.  Comparing this data to results 
from Magnetic Resonance Spectroscopy (MRS) will help confirm the possible presence of 
ongoing infection and reactive gliosis in the areas investigated.  Quantitative techniques such 
as MRS and relaxometry in conjunction with MRI analysis may be necessary to determine 
early diagnostic outcomes, especially if one wishes to test the full impact and efficacy of 
HAART (Chang et al. 2004; Prado et al. 2011).   Repeated scanning and manual segmentation 
of this same cohort and different ages will help track the ongoing processes occurring.  In 
addition, 3D analysis comparing changes in shape with increasing age, using the manually 
segmented data, will help track which regions within each of these structures are most 
affected by HIV, as opposed to merely comparing the whole volume of each structure.  
Similarly, 3D analysis could be used to identify the regional boundaries where automated 
and manual segmentation differ the most.   
Development of a childhood brain atlas to be used in the segmentation and parcellation 
protocol in FreeSurfer would be advantageous.  Also given the amount of variation between 
sexes, as well as variation between individuals from differing ethnic origins, it should perhaps 
be posed that, although extremely costly and time consuming, unique atlases should be 
generated for these biological variations.   
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CHAPTER 5 CONCLUSION 
Our results are in good agreement with results from other studies.  Overall findings of 
this study suggest that perinatal HIV-1 infection targets select structures of the basal ganglia 
in Xhosa children at age 5 years.  Both the NA and Pu are enlarged bilaterally in infected 
children.  In contrast, the CC is smaller compared to uninfected children.  Global atrophy may 
be masked by current ongoing infection and processes within the CNS.  Although the odds of 
escaping the adverse effects linked to HIV-1 infection are low, our results suggest that earlier 
treatment aids in mitigating disease progression in the brains of 5-year-old Xhosa children.  
It appears that treatment should occur before plasma viral load reaches high levels to 
decrease the associated pathology to the basal ganglia.  Damage to the corpus striatum that 
occurs despite treatment is possibly dictated by the rate of the initial insult (Andronikou et 
al. 2014; Becker et al. 2011).  Although PVL was suppressed in all infected children at the 
time of scanning in our study, poorer immune health, as evidenced by lower CD4/CD8 ratios, 
was associated with larger caudal volumes.  
Although there may be no group differences in the volumes of some brain structures, 
there may still exist differences in functional cognitive abilities which may only present in 
neurocognitive testing (Depas et al. 1995).  Further studies of this nature would assist in 
developing efficient methods for management of HAART administration protocols in the 
hopes of alleviating some of the CNS damage in response to HIV infection. 
Finally, our results demonstrate that automated segmentation using FreeSurfer may 
introduce bias into subcortical structure volumes in Xhosa children at, or around, 5 years of 
age.  In view of these findings, caution should be employed when using automated measures 
to assess the effects of pathology on brain regions, especially in populations different to 
those in whom the atlases and automated methods were developed.  We observed that 
reliability and validity differed between the pathological and normal brains in our study, and 
demonstrated that some statistical tests of reliability may be too lenient thus eliciting false 
confidence in the results.  Thus, the efficacy of the intended automated measure should be 
compared to manually segmented data in a subset of the sample via multiple reliability tests.  
This would assure that the study measure portrays a truthful image of the pathology, without 
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APPENDICES: Ethnic Group Analysis 
A limitation of the present study relates to sampling.  Upon reviewing the sample 
demographics, it became apparent that ethnicity and sex of participants needed further 
investigation to test for possible confounding effects. 
Ethnicity as a possible confounding factor 
There were only 11 (14.1%)  Cape Coloured children within the sample.  Most of these 
children were uninfected controls with only two being HIV-1 infected.  There were no Cape 
Coloured children in the deferred treatment group and only one in each of the early 
treatment arms.  In contrast, the representation of Xhosa children in each of the groups was 
nearly equal.  The vast majority of the infected children were Xhosa.  A Chi-square test 
revealed that the number of participants in each diagnostic group differed significantly 
between ethnic groups (χ2 (one, N=78) =6.20, p=0.013).   
Table A.1 Number of children per ethnic group in each diagnostic group 
ART-Def ART-40W ART-96W
n n n n n
(%) (%) (%) (%) (%)
9 0 1 1 11
(11.5) (0) (1.3) (1.3) (14.1)
18 17 16 16 67
(23.1) (21.8) (20.5) (20.5) (85.9)
27 17 17 17 78












† p < 0.1, * p < 0.05, *** p < 0.001 
Figure A.1 shows means and standard deviations of structural volumes between children 
from different ethnic groups.   
Volumes are larger in Xhosa children compared to Cape Coloured children bilaterally in the 
caudate and the right Pu, causing total volumes for the caudate + NA bilaterally and right 
lentiform nucleus to also be larger.   
Comparisons for the volumes of structures between uninfected Cape Coloured and 
uninfected Xhosa control participants were investigated.  Significant differences in structural 
volumes of the left caudate (F(1,25)=10.19; p=0.004) and right caudate (F(1,25)=10.92; 
p=0.003) and corpus callosum (F(1,25)=13.06;  p<0.001) were observed. 
Ethnicity meets the criteria of a confounding factor.  Ethnicity has been shown to be 
associated with both the outcome and exposure variable.  Ethnicity also does not occur as a 
direct result of the exposure variable.  Due to the potential confounding effects of ethnicity 
on structural brain volumes, and the fact that the Treatment groups are not well matched 
for ethnicity, we removed the Cape Coloured children from all further analyses.  
Figure A.1 Structural volumes between ethnic groups 
